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Autophagy is a tightly regulated process that sequesters and delivers proteins and other 
cellular substances for degradation in the lysosome. Dysfunction of autophagy has been 
implicated in many diseases including neurodegenerative diseases, cancer, and infectious 
diseases. Beta-propeller Protein-Associated Neurodegeneration (BPAN), an early-onset 
neurodegenerative disease, is caused by mutations in WIPI4, a member of the WD repeat 
domain phosphoinositide-interacting family. This thesis identifies WIPI4 as a regulator of the 
closure of autophagosomes. Although many proteins have been found to regulate the late 
stage of autophagosome formation, the exact mechanism of this process has remained 
unclear. This thesis explored the regulatory mechanism of GABARAP by WIPI4. GABARAP is 
a potential closure regulator and is also required for expansion and fusion steps of autophagy. 
I identified that WIPI4 regulates the stability and trafficking of GABARAP. Further studies 
identified UBR5, an N-recognin, to be a potential GABARAP-targeting E3 ligase. In WIPI4 
depleted HeLa cells, there is an increased interaction between UBR5 and GABARAP. The 
negative regulatory activity of UBR5 on GABARAP is dependent on its E3 ligase activity. In 
addition, mutation of the N-degron of GABARAP reduces its ubiquitination by K48-linked 
chains, suggesting that GABARAP may be an N-end rule pathway substrate. Altogether, this 
thesis furthers our understanding of the mechanism of autophagosome closure and identifies 
a potential novel GABARAP E3 ligase.  
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Chapter 1 Introduction 
The fact that intracellular proteins are turning over was only discovered following the usage of 
radioactive isotopes for labelling organic compounds in the 1940s (Rittenberg et al., 1939) and 
has changed the paradigm that regulation of cellular processes occurs mostly at the 
transcriptional and translational level. With the discovery of the lysosome (Duve 1953) and 
later the ubiquitin-proteasome system (Hershko 1980), protein degradation is found to be 
tightly regulated for the following purposes: providing the cell with amino acids and energy for 
the synthesis of new proteins, clearance of damaged or misfolded proteins and termination of 
signalling pathways that are no longer functioning at the proper level. 
1.1 Lysosomal pathways  
The lysosomal/vacuolar system is a discontinuous membrane system that digests both 
endocytosed receptor-ligand complexes and phagocytosed extracellular contents, as well as 
cytoplasmic proteins and organelles (autophagy). The digestive process involves maturation 
from early endosomes to the acidic lysosomes containing hydrolytic enzymes; or from early 
phagophores to autolysosomes. The two sub-routes overlap at multiple steps, such as 
microautophagy and amphisome formation in macroautophagy.  
Autophagy refers to a series of tightly modulated processes that sequester and deliver proteins 
and other cellular constituents to the lysosome for degradation. It was first found to be 
important in protein catabolism during starvation, when autophagic degradation promotes the 
recycling of cellular nutrients, thereby enabling cell survival. It is now well-recognized that basal 
autophagy in nutrient-rich conditions is also involved in maintaining cellular homeostasis. This 
quality control by the degradation of damaged and dysfunctional proteins and organelles is 
particularly crucial in post-mitotic tissues, like neurons and muscle, where the cells are 
protected by autophagy from the toxic effects of dysfunctional proteins that cannot be 
diluted via cell division. Autophagy is required for the elimination of malfunctioning 
organelles and proteins. Thus, it is required for the proper functioning of cells. Dysfunction of 
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autophagy has been found in many diseases, including neurodegeneration diseases, cancer, 
and ageing (reviewed in Frake et al., 2015). There are three types of autophagy: 
macroautophagy, microautophagy and chaperone-mediated autophagy (CMA).  
1.1.1 Macroautophagy  
Macroautophagy (hereafter as autophagy) involves the formation of a bowl-shaped isolation 
membrane that grows and engulfs the cargo. Eventually, the rims of the bowl meet and seal. 
The sealed autophagosome loses all autophagy-related genes (ATGs) on the surface except 
for ATG81 family proteins. It then fuses with a lysosome to form an ‘autolysosome’ and degrade 
the substrate inside. The canonical autophagy can be broadly classified into initiation, 
nucleation, expansion, closure and fusion. Each step is tightly regulated to respond to various 
stimuli (Ravikumar 2009). 
1.1.1.1 Autophagy initiation  
1.1.1.1.1 ULK1/2 complex  
The ULK1/2 complex is one of the most upstream elements in the machinery and acts as a 
signalling node for several signalling pathways that induce macroautophagy. It consists of 
UNC51-like kinase 1 (ULK1), or its homologue UNC51-like kinase 2 (ULK2) together with 
Autophagy-related 13 protein (ATG13), 200 kDa FAK Family Kinase-Interacting Protein 
(FIP200) and Autophagy-related 101 protein (ATG101) (Hara et al., 2008). As a serine/ 
threonine-specific kinase, the active ULK1 complex then phosphorylates beclin1 (BECN1) in 
mammalian cells, a regulatory subunit of phosphatidylinositol 3-kinase class 3 (PI3KC3, 
VPS34) complex, the next complex in the cascade. It also phosphorylates FIP200 and ATG13, 
which additively enhance the kinase activity of ULK1, including its autophosphorylation 
capabilities (Ganley et al., 2009). In addition, active ULK1 phosphorylates ATG14, vacuolar 
protein sorting 34 (VPS34), ATG101 (Hosokawa et al., 2009; Wold et al., 2016), which helps 
with recruitment of the VPS34 complex at the autophagosome formation site.  
1: Nomenclature for yeast, worm and mammalian autophagy genes: all letters of mammalian protein symbols are in upper-case, 
same with their gene symbols but italic; only the first letter of yeast protein symbols is in upper-case and all the others in lower-
case, same with their gene symbols but italic; all letters of worm protein symbols are in upper-case, but their gene symbols should 
be italic and all in lower-case. And there is a hyphen between the alphabets and the number for autophagy proteins and genes in 
C. elegans.  
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The interaction between ULK1 and ATG13 depends on their phosphorylation status, which is 
regulated by kinases like the mechanistic target of rapamycin (mTOR) and AMP-activated 
protein kinase (AMPK) (Ganley et al., 2009). The phosphorylation of ATG13 and ULK1 by 
mTOR under nutrient-rich conditions hinders the interaction between ULK1 and ATG13, 
thereby inactivating the complex. GABARAP loss of function decreased ATG13-pSer318 
levels, suggesting an attenuation of ULK1 kinase activity (Joachim et al., 2015). GABARAP 
interacts with ULK1 independent of lipidation but dependent on the LIR domain. 
1.1.1.1.2 Upstream signalling 
mTOR  
mTOR (mammalian/mechanistic target of rapamycin) is a 289 kDa serine-threonine kinase 
controlling growth and metabolism in response to nutrient and energy cues (reviewed in 
Laplante and Sabatini, 2012). It exists as the catalytic unit of two multimeric complexes, 
mTORC1 and mTORC2 (Jacinto et al., 2004). Both mTORC1 and mTORC2 also contain 
mLST8 (mammalian lethal with Sec13 protein 8, also known as GβL) and an inihibitory subunit 
DEPTOR (DEP domain-containing mTOR interacting protein) (Peterson et al. 2009). mTORC1 
also contains RAPTOR (regulatory protein associated with mTOR), which recruits substrates 
and is required for the subcellular localization of mTORC1 (Saxton et al., 2017). 
mTORC1 mediates inhibitory phosphorylation of ULK1, ATG13 (Hosokawa et al., 2009), 
transcription factor TFEB and other autophagy genes under nutrient-sufficient conditions. 
mTORC1 regulates cell growth and proliferation by phosphorylation of 4E-binding protein 1 
(4EBP1) and ribosomal protein S6 kinase polypeptide 1 (S6K) (Guertin and Sabatini, 2007).  
The mTORC1 complex reacts to signals like growth factors, genotoxic stress, energy status, 
oxygen availability and amino acid availability (reviewed in Laplante and Sabatini, 2012). 
Amino acid starvation leads to the inactivation of mTORC1, which lifts the inhibitory 
phosphorylation of ULK1, allowing downstream macroautophagy to proceed. Also, TFEB is no 
longer phosphorylated when mTORC1 is inhibited, and can translocate from cytoplasm to the 
nucleus, where it promotes the transcription of genes involved in macroautophagy and 
lysosome biogenesis.  
The activity of mTORC1 is upregulated by the Leucine metabolite acetyl-coenzyme A (AcCoA) 
through the EP300-mediated acetylation of RAPTOR at K1097 (Son et al., 2019). mTORC1 is 
sensitive to rapamycin (Hara et al., 2002). Rapamycin is an anti-fungal macrolide produced by 
4 Introduction 
 
the bacterial species Streptomyces hygroscopicus. Rapamycin binds to FKBP12, and this 
complex then binds to mTOR to narrow the catalytic cleft and partially occlude substrates from 
the active site (Yang et al., 2013).  
mTORC2 is primarily involved in the regulation of the cytoskeleton and also regulates 
autophagy through the PKCα/ β-actin cascade (Renna et al., 2013). The main difference 
relative to the mTORC1 complex is the replacement of RAPTOR by RICTOR (rapamycin 
insensitive companion of mTOR), and mTORC2 is insensitive to acute rapamycin treatment. 
AMPK  
AMPK activates autophagy at three levels. It detects the energy levels in cells and inhibits 
mTORC1 complex via TSC2 and Raptor in response to decreasing ATP to AMP ratios, such 
as in glucose starvation (Inoki et al., 2002). In the same conditions, AMPK also directly 
catalyzes activating phosphorylation events on ULK1 by binding to S757, a site also subject to 
inhibitory phosphorylation by mTORC1 (Lee et al., 2010). ULK1 phosphorylation sites have 
also been identified at either S467 and S555 (Egan et al., 2011) or S317 and S777 (Kim et al., 
2011). Phosphorylation at these sites upregulates the kinase activity of ULK1. Inhibition of 
AMPK-mediated phosphorylation of ULK1 has negative implications on bulk macroautophagy. 
AMPK also stimulates autophagy by phosphorylating BECN1 of the VPS34 complex (Russell 
et al., 2013).  
mTOR independent pathways 
Trehalose stimulates clearance of autophagy substrates, including mutant Huntingtin and the 
A30P and A53T mutants of α-synuclein, by blocking cellular glucose import through inhibition 
of SLC2A (also known as GLUT) transporters (Mardones & Rubinsztein et al., 2016). Another 
mechanism of mTOR independent autophagy regulation is via intracellular calcium (Ca2+) 
levels. Ca2+ has been shown to control various stages of autophagic flux (reviewed in Bootman 
et al., 2018). However, there is no consensus about whether cytosolic Ca2+ signals trigger or 
inhibit autophagy. Different Ca2+ channels and Ca2+ sources have been shown to have different 
effects on autophagy. In addition, the JNK/Beclin/PI3KC3 complex, which promotes 
autophagy, is regulated by starvation but not by mTOR (Sarkar et al., 2014). 
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1.1.1.2 Nucleation 
1.1.1.2.1 VPS34/PI-3 kinase complex  
The vacuolar protein sorting-34 (Vps34) is an autophagy‐specific class III phosphatidylinositol-
3-kinase (PI3K), associates with BECN1 (mammalian ATG6), and subsequently recruits the 
sensor of membrane curvature ATG14 and phosphoinositide‐3‐kinase regulatory subunit 4 
Vps15 (p150) (Kihara et al., 2001) and nuclear receptor binding factor 2 (NRBF2) (Lu et al., 
2014) to the pre-autophagosomal structure. An active VPS34 kinase complex produces PI(3)P, 
which recruits WIPIs (Axe et al., 2008). ATG14 has also been reported to promote membrane 
tethering and fusion of autophagosomes to lysosomes by temporally and spatially controlling 
the fusogenic activity of the autophagic SNARE complex (Diao et al., 2015). 
The Class III PI3K complex is regulated by several interactors, including the VPS34 activator 
autophagy and beclin 1 regulator 1 (AMBRA1, originally ‘activating molecule in Beclin 1‐
regulated autophagy’), and BECN1 inhibitor BCL2, which also interacts with ATG12 (Liang et 
al., 1999; Pattingre et al., 2005; Fimia et al., 2007; Zalckvar et al., 2009; Rubinsztein et al., 
2011).  
Macroautophagy can be inhibited at the early stages with inhibitors of the class III PI3K 
complex: 3-methyladenine (3-MA) (Seglen and Gordon, 1982) and wortmannin (Powis et al., 
1994), which both also target the class I PI3K (Wu et al., 2010). Several specific Class III PI3K 
inhibitors have been identified recently (Bago et al., 2014; Ronan et al., 2014; Pasquier et al., 
2015). 
1.1.1.2.2 WIPIs serve putative roles in autophagy 
PROPPINs (β-propellers that bind phosphoinositides, also called WIPIs (WD repeat domain 
phosphoinositide-interacting)), are the only known PtdIns3P-binding proteins with conserved 
PI(3)P effector functions in autophagy from yeast to human (Busse et al., 2013). Subsequently, 
WIPIs recruit downstream regulators onto the formation site and ultimately facilitate the 
formation of autophagosomes. WIPIs are ubiquitously expressed (reviewed in (Proikas-
Cezanne et al., 2015)). 
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1.1.1.2.2.1 Ancestral WIPIs 
1.1.1.2.2.1.1  The evolutionary distance between mammalian and yeast WIPIs 
There are four human WIPIs (WIPI1 to WIPI4) along with their splice variants, and three 
orthologs in the yeast (Atg18, Atg21, Hsv2). The four human WIPI members were all described 
independently based on their sequence homology to yeast Atg18. Phylogenetic analysis has 
demonstrated that human WIPI proteins are divided into two paralogous groups, one 
containing human WIPI1 and WIPI2 and the ancestral yeast Atg18, and the other containing 
human WIPI3 and WIPI4 and C.elegans Epg-6 (Proikas-Cezanne et al., 2004; Polson et al., 
2010; Behrends et al., 2010). It is suggested that vertebrates have undergone an additional 
duplication in each of the two paralogous groups, suggesting that the four human WIPI proteins 
may have distinct roles in autophagy. Atg18 is evolutionarily closer to WIPI1/ WIPI2 than to 
WIPI3/WIPI4 (Krick et al., 2008). Atg21 is of similar evolutionary distance to the Atg18/WIPI1-
WIPI2 group and WIPI3-WIPI4 group, so it is difficult to unambiguously identify its homologues 
in the PROPPIN family based on sequence similarity (Hoa Mai Nguyen et al., 2018). Hsv2 is 
closer to the WIPI3-WIPI4 group (Hoa Mai Nguyen et al., 2018). 
1.1.1.2.2.1.2 Functions of ancestral WIPIs 
I. Atg18-Atg2 complex interacts with Atg9 vesicles 
Yeast Atg18 functions both in autophagy and in the vacuole targeting pathway. In the 
autophagy pathway, Atg18 forms a complex with Atg2 (Obara et al., 2008) and Atg18 
membrane binding is dependent on both Atg2 and PI3P. Atg18 alone does not bind to PI3P-
containing liposomes, although Atg18 can bind to liposomes containing PI(3,5)P2. The N and 
C-terminals of Atg2 contribute to highly curved membrane-binding (vesicles with diameters 
<50 nm) independent of each other (Kotani et al., 2018).  However, the Atg2 C-terminal not 
only binds membranes with its amphipathic helix but also is required for the specific localization 
on the PAS since it interacts with Atg18 which binds to PI3P. The N-terminal of Atg2 is not 
required for PAS localization, but functions in autophagosome expansion exerted after its 
localization.  
Atg18 is essential for the retrieval of Atg9 from mature autophagosomes (Reggiori et al., 2004).  
Atg2-Atg18 complex directly interacts with Atg9 (Suzuki et al., 2007; Wang et al., 2001). The 
Atg2-Atg18 complex localizes to the highly curved edge of the isolation membrane during its 
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expansion (Suzuki et al., 2013; Graef et al., 2013). Since the Atg9 vesicles are of a diameter 
of 30~60 nm (Yamamoto et al., 2012), they may be easily tethered by Atg2 onto edges of 
expanding phagophores with the help of Atg18. 
Epistasis analysis in C. elegans indicated that the ULK1, atg14, the LC3 conjugation system, 
atg-9, and atg-18 are epistatic to epg-6 (WIPI4 homolog) and atg-2 (Lu et al., 2011). Atg18 
loss of function reduces autophagosome numbers, while epg-6 loss-of-function causes the 
accumulation of autophagosomes. Epg-6 directly interacts with atg-2 and regulates the 
distribution of atg-9. 
II. Yeast WIPI family proteins also function in selective autophagy and microautophagy 
In the vacuole targeting pathway (a selective autophagy pathway in yeast), Atg18 forms 
complex with the PI(3)P 5-kinase Fab1, the lipid phosphatase Fig4, Vac7, and Vac14 (Botelho 
et al., 2008; Jin et al., 2008). Atg18 also functions in microautophagy (Oku 2006; Guan 2001; 
Krick et al., 2008).  
The other two Atg18 homologues in yeast are Atg21 and Hsv2 (Ygr223cp). Atg21 regulates 
lipidation and localization of Atg8 during uptake of Aminopeptidase I by selective autophagy 
(Stromhaug et al., 2004) and plays a similar role with Atg18 in the vacuole targeting pathway 
(Meiling-Wesse et al., 2004); it directly interacts with the coiled-coil domain of Atg16 and with 
Atg8. Hsv2 promotes efficient piecemeal of the nuclear (PMN) (Krick et al., 2008).  
No dramatic influence on autophagy was observed when overexpressing Atg21, Atg18 or 
YGR223c (Krick et al., 2008). 
1.1.1.2.2.2    Structural analysis of Hsv2 and WIPI3 
All PROPPINs are seven-β sheet proteins (Diagram 1.1 A). Each blade consists of four anti-
parallel β-strands (from i to iv). Overall, the structure resembles a ‘disk’ with ~50 Å of diameter 
and 25 Å of thickness (Liang et al., 2019).  
Hsv2, the yeast homolog of WIPI3/4, contains two Leu/ Phe-Arg-Arg-Gly (L/FRRG) 
phosphoinositide-binding sites on blades 5 and 6, which are much larger than the other two 
PI3P binding domains, FYVE and PX domains. Mutation of either of the PI3P binding sites 
disrupts the lipid-binding ability of Hsv2. While both L/FRRG sites are equally important for 
PI3P binding, site 2 on Blade 6 seems to be more important for binding to PI(3,5)P2. Recently, 
WIPI3 structural analysis found that WIPI3 forms a similar structure to Hsv2, although the 
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L/FRRG motif on Blade 6 favours PI3P, which is different from Hsv2 (Liang et al., 2019). All 
WIPIs binds efficiently to PI3P, PI(3,5)P2 and PI5P, suggesting that the position of the 
phosphoryl group relative to the membrane matters the most, rather than the detailed 
positioning of the inositol hydroxyl groups. Furthermore, WIPI4 is the only PROPPIN that has 
only one L/RFFG site and does not bind relatively low concentrations of PI3P (Baskaran et al., 
2012).  
At the same time, on the interface of Hsv2 and the membrane, there are three prominent 
hydrophobic residues in the Blade 6 β3-β4 loop, W267A/Y272A/F273A, which are required for 
membrane binding. These binding sites are conserved among all PROPPINs, except for 
WIPI4, which only contains one of these membrane-penetrating aromatic residue (Y291) in the 
Blade 6 β3-β4 loop (Diagram 1.1 B). The structural analysis of Hsv2 indicates that PROPPINs 
are initially targeted to membranes through nonspecific electrostatic interactions and then 
retained at the membrane by binding to PIP (Baskaran et al., 2012). 
The yeast Atg2-binding site of Hsv2 is on Blade 2, and the 3D structure suggests that the lipid-
binding site and Atg2 binding site are on different facets, therefore do not disrupt each other 
(Baskaran et al., 2012; Krick et al., 2012). The ATG2 binding site of WIPI4 is on its Loop3 
between Blade 3 and Blade 4 (Zheng et al., 2017), which is also opposed to its PI3P binding 
site (on Blade 6 if similar with WIPI3). WD-40 repeats often serve as platforms to assemble 
functional complexes through the hotspot residues of their domain surfaces (Wang et al., 2015) 
and are one of the most enriched functional domains in the autophagy system (Behrends et 






















1.1.1.2.2.3  Mammalian WIPIs 
A pool of WIPI1 localizes to endosomes and regulates trans-Golgi-endosomal protein 
trafficking in addition to controlling endosome and autophagosome dynamics (Muller et al., 
2015). WIPI1 depletion stimulated the phosphorylation of MTOR itself at Ser-2448 and 
mTORC1 downstream target p70S6K in both melanocytes and Human MNT-1 melanoma 
cells, suggesting that WIPI1 suppresses the target of rapamycin complex 1 (TORC1) activity 
(Ho et al., 2011), although the mechanism is unknown. 
There are four WIPI2 splice variants. WIPI2b binds and recruits ATG16L1 (Dooley et al., 2014) 
onto phagophores by interacting with PI(3)P and PI(5)P (Vicinanza et al., 2015).  In HEK293A 
cells, silencing of WIPI2 suppresses LC3 puncta formation (Polson et al., 2010). When WIPI2 
is downregulated, ATG9 accumulates at phagophores (Orsi et al., 2012). Therefore, WIPI2 
may help the retrieval of ATG9 from early autophagosomes, similar to what has been reported 
for yeast Atg18 (Obara et al., 2008). WIPI2 has also been found to be overexpressed in kidney 
and pancreas cancers (Proikas-Cezanne et al., 2015). 
Although WIPI1, WIPI2 and WIPI4 have all been reported to react to PI3P signals in response 
to starvation, and all WIPIs interact with ATG2 in mammalian cells (Bakula et al., 2017), 
evidence from ancestral WIPIs indicates that WIPI4 may function downstream of WIPI1/2 in 
the autophagy pathway. Recently, it was verified by in vitro experiments that WIPI4/1 facilitates 
ATG2A-mediated lipid transfer between PI3P containing large unilamellar vesicles. The PI3P 
effector WIPI4 on PI3P-containing vesicles associates with ATG2A stably, thereby facilitating 
ATG2A-mediated tethering and lipid transfer between PI3P-containing vesicles and PI3P-free 
vesicles. WIPI1 also promotes the lipid transfer by ATG2, although no direct interaction 
between WIPI1 and ATG2 was found in vitro (Maeda et al., 2019). Instead, WIPI1 induces 
clustering of liposomes.  The function of WIPI2 and WIPI3 in lipid transfer remains to be tested.  
WIPI3 and WIPI4 may also be involved in the control of autophagy upstream of PI3P 
production. WIPI3 associates with FIP200 and AMPK-activated TSC complex at lysosomes 
and regulates mTOR. WIPI4-ATG2 translocates from the AMPK-ULK1 complex to nascent 
autophagosomes in response to LKB1-mediated AMPK stimulation (Bakula et al., 2017). 
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1.1.1.3 Autophagosome elongation/expansion 
Expansion of the autophagosomal membrane requires the supply and correct composition of 
the lipids, as well as relevant protein regulators. The known events which happen during this 
stage are LC3-II conjugation, transient interaction of phagophores with ATG9 vesicles and lipid 
transfer by ATG2.  
1.1.1.3.1 LC3-II conjugation 
The conjugation of ATG8s/LC3 to membranes that become autophagosomes is a defining 
event in autophagy, which involves two ubiquitin-like reactions. 
ATG5-ATG12-ATG16L1 conjugation system  
ATG7 (E1-like) activates ATG12 (ubiquitin-like molecule), and ATG10 (E2-like) attaches the 
C-terminal glycine of ATG12 irreversibly to an internal lysine of ATG5 (Mizushima et al., 1998). 
The ATG5-ATG12 conjugate then non-covalently interacts with the N-terminal of ATG16L1 
and oligomerizes to form a complex of approximately 800 kDa. This complex locates to the 
outer membrane of the phagophore and disassociates upon maturation of autophagosomes 
(Suzuki et al., 2001). It is reported that ATG16L1 promotes ATG5 membrane binding by 
releasing the inhibition of membrane binding by ATG12 (Romanov et al., 2012). ATG16L1 
regulates the localization of the ATG5–ATG12 conjugate to the cytoplasmic face of 
phagophore (in yeast) / isolation membranes (higher eukaryotes) and also specifies the site of 
ATG8/LC3 lipidation (Fujita et al., 2008). 
LC3-PE conjugation system  
This cascade starts with the cleavage of pro-LC3 at its C terminus by the cysteine protease 
Autophagy-related 4 (ATG4) to expose a free C-terminal glycine and generate cytosolic LC3-
I. ATG7 activates it as an E1-like enzyme and ATG3 acts as an E2-like enzyme (Tanida et al., 
2001). The ATG5-ATG12-ATG16L1 complex is thought to function as an E3-like enzyme with 
ATG12 binding ATG3. The C-terminal glycine of LC3 is specifically targeted to the ATG5-
ATG12-ATG16L1 complex and then is covalently conjugated to phosphatidylethanolamine 
(PE) to form LC3-II on both inner and outer membranes (Ichimura et al., 2000). After 
completion of autophagosome formation, the LC3-II remains associated with the 
autophagosomes. After fusion, LC3-II on the cytoplasmic face is recycled back via the action 
of ATG4B, while the luminal LC3-II is broken down (Korolchuk et al., 2010). It is also suggested 
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that ATG3 is an additional conjugation target of ATG12 and ATG12-ATG3 is required for 
efficient basal autophagy flux, as well as late endosome function through interaction with 
ESCRT complex (Murrow et al., 2015). The deacetylation of LC3 promotes the cytosolic 
translocation of a nuclear LC3 pool, which is required for its lipidation in starvation conditions 
(Huang et al. 2015).  
1.1.1.3.2 ATG9 trafficking  
ATG9 is the only transmembrane protein of all core ATG proteins and is thought to deliver 
membranes to autophagosomes and autophagosome precursors (Reggiori et al., 2004; 
Yamamoto et al., 2012; Young et al., 2006; Karanasios et al., 2016). Autophagosome 
formation is inhibited after downregulation of ATG9 in yeast and mammalian systems (Zhuang 
et al., 2017). Previous findings have shown that the trafficking of ATG9 from the plasma 
membrane to the recycling endosomes via early endosomal compartments is important for the 
biogenesis of autophagosomes (Puri et al., 2014).  
Under nutrient-sufficient conditions, ATG9A mainly traffics through the medial and TGN of the 
Golgi and endosomes, but during amino acid starvation, some perinuclear ATG9A derived 
from both the Golgi and recycling endosomes translocates onto vesicular-tubular structures 
which are partially positive for autophagosome markers (Orsi et al., 2012), and is similar in 
yeast (Mari et al., 2010). This vesicular ATG9A compartment interacts transiently with but is 
not incorporated into phagophores (Karanasios et al., 2016). 
The ULK1/2 complex (Young et al., 2006) and SRC kinase (Zhou et al., 2017) regulate the 
ATG9 exit from the Golgi by phosphorylation of its interactors AP1 and AP4 (Guo et al., 2012). 
Sphingomyelin phosphodiesterase 1 controls ATG9A trafficking from the recycling endosome 
(Corcelle-Termeau et al., 2016) and its dysregulation impairs autophagosome closure. p38IP, 
a p38 MAPK-interacting protein (Webber et al., 2010), and Sorting nexin-18 (Søreng et al., 
2018) are reported to control ATG9 trafficking from the Golgi and recycling endosomes, 
respectively. 
Recently, additional components of ATG9A-positive membranes have been identified (Judith 
et al., 2019). In amino acid starvation (Earle’s saline), representative proteins enriched in 
ATG9A-positive membranes are RAB1A, ARFIP1, ARFIP2, SH3GLB1 (BIF-1 or endophilin B), 
phosphatidylinositol 4 kinases (PI4KIIα and PI4KIIIβ) and TRAPPC5. In nutrient-rich media, 
GOLGA2, TGOLN2, and SEC22A were enriched. The levels of AP4 subunits are unchanged. 
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These proteins potentially modulate the composition of ATG9A-positive membranes or are 
transported together with ATG9 vesicles and function on autophagosomes.  
RAB1B (Kakuta et al., 2017) controls trafficking between the ER and Golgi (Wang et al., 2015) 
and the Golgi and recycling endosomes (Marie et al., 2009). They are found to localize on 
ATG9A-GFP–positive vesicles. Yeast Ypt1 (RAB1 homologue), which is present on COPII 
vesicles and is necessary for the tethering of COPII vesicles to the Golgi during secretion, was 
also found on yeast Atg9 vesicles (Kakuta et al., 2012; Yamamoto et al., 2012). Ypt1 and its 
GEF TRAPIII localize to the PAS upon starvation (Lynch-Day et al., 2010), and TRAPIII also 
regulates ATG9A/Atg9 traffic (Kakuta et al., 2012; Lamb et al., 2016). 
BIF-1 (Endophilin 1), ARFIP1 and ARFIP2 are all Bin/Amphiphysin/Rvs (BAR) domain-
containing proteins. BIF-1 (Takahashi et al., 2011) and Dynein (Takahashi et al., 2016) are 
required for ATG9A-positive vesicle formation from recycling endosomes.  
ARFIPs sense and generate membrane curvature (Peter et al., 2004; Frost et al., 2009).  
ARFIPs bind to the TGN depending on its amphipathic helix and the BAR domain (Cruz-Garcia 
et al., 2013). The amphipathic helix enables the specificity of ARFIPs’ binding to 
phosphatidylinositol 4-phosphate (PI4P)–containing liposomes (Cruz-Garcia et al., 2013). 
Depletion of ARFIP1 does not regulate autophagy.  However, depletion of ARFIP2 (also 
termed partner of Rac1, a Rho family GTPase (POR1)) downregulates autophagy (Judith et 
al., 2019). 
PI4KΙΙα promotes autophagosome-lysosome fusion (Wang et al., 2015) and is also recruited 
by GABARAP, but it was still accumulated on autophagosomes in GABARAP family depleted 
cells (Vaites et al., 2019).  
1.1.1.3.3 Lipid transfer by ATG2 
Structure of ATG2 family proteins 
There are two redundant ATG2 homologs in human, ATG2A and ATG2B. ATG2 proteins 
contain evolutionarily conserved Chorein_N (Pfam ID: PF12624), ATG_C (Pfam ID: PF09333), 
and ATG2_CAD (Pfam ID: PF13329) domains (Diagram 1.2A) (Chowdhury et al., 2018). 
Chorein_N and ATG_C are conserved with the N and C terminal of VPS13 (Pfisterer et al., 
2014), a paralog of VPS13A/Chorein (Velayos-Baeza et al., 2004). The Chorein_N and ATG_C 
regions are also required for the localization of ATG2A to autophagosome-forming sites and 
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LDs (Tamura et al., 2017). The C-terminal localization region (CLR) (residues 1,723–1,829) 
preceding ATG_C contains an amphipathic α-helix and is also required for the localization of 
ATG2A to both phagophores and LDs (Velikkakath et al., 2012; Tamura et al., 2017). 
Mammalian ATG2 colocalizes with LC3, as well as with early autophagosomes decorated with 
ULK1, WIPI1 and ATG5 (Velikkakath et al., 2012).   
The binding site of WIPI4 on ATG2 is located between the CAD domain and the CLR domain, 
but the exact site is disputable. One report suggested residues 1344, 1373, 1503 of ATG2A 
(Chowdhury et al., 2018). Whereas, another group suggested an evolutionarily conserved 
aromatic H/YF motif (1524/1525) (Zheng et al., 2017).  A third study found amino acid 1358-
1404 to be required for WIPI4 binding (Maeda et al., 2019).  
Residue 240–920 of yeast Atg2 form repeated β-strands abundant with hydrophobic residues, 
where phospholipids move along (Diagram 1.2A). Residue 1,235–1,243 and 1,264–1,268 of 
yeast Atg2 are required for the interaction with Atg9, and the interaction with Atg9 promotes 
the interaction of Atg2 with Atg18 and restricts the localisation of Atg2-Atg18 complex to the 
extremities of the phagophore (Gómez-Sánchez et al., 2018). Another study found that aa 2-
46 and 1269-1347 of Atg2 are required for its interaction with Atg18 and Atg9, while aa 10-12 
are required for its localisation to the ER, suggesting that membrane localisation of Atg2 n 
terminal is required for its interaction with Atg9 and Atg18 (Kotani et al., 2018). Moreover, 
1347-1373 is required for its localization to the PAS. The yeast ATG_C also shares similarities 
with the Golgi-localized protein of maize APT1, which is involved in the secretory pathway (Xu 
et al., 2006). S249 and S1086 of yeast Atg2 can be phosphorylated by Atg1, although the 
function is unknown (Papinski et al., 2014). 
ATG2A/B forms a rod-shaped protein with 20 nm in length, binding the membrane with both 
its N-tip and CAD-tip (containing CAD and CLR domains) (Diagram 1.3A) (Chowdhury et al., 
2018). The binding to the membrane is dependent on lipid packing defects, independent of the 
lipid type. ATG2A/Atg2 tethers small unilamellar vesicles vesicles (SUVs) of high curvature 
(diameter <80 nm) independent of PI3P (Chowdhury et al., 2018; Kotani et al., 2018), but 
cannot tether large unilamellar (LUVs) (>140 nm), possibly because its CAD-tip cannot bind 
stably the low curvature membrane containing fewer packing defects (Chowdhury et al., 2018). 
However, WIPI4-ATG2 tethers LUVs and facilitates the lipid transfer between LUVs in vitro, 
possibly by stabilizing the phagophore localization of ATG2 C-termini.  





Two models of lipid transfer by ATG2 family proteins 
Liquid chromatography/tandem mass spectrometry show that ATG2 family proteins solubilize 
lipids and that each ATG2 molecule can bind to ∼20 lipid molecules. Structural analysis of 
ATG2A-WIPI4 complex indicates that WIPI4 flexibly associates with ATG2A in a region close 
to its CAD tip, inducing no significant conformational change in ATG2A (Diagram 1.3A). The 
binding with WIPIs may enable the CAD-tip to specifically and tightly localize to PI3P containing 
membranes. WIPI4-mediated tethering is required for the transfer between low curvature 
membrane LUVs (Chowdhury et al., 2018), suggesting that the lipid transfer requires stable 
tethering, which is called the ‘bridge model’ (Diagram 1.3B). Structural analysis of yeast Atg2 
suggests that its N-tip extracts phospholipids through weakly binding the acyl chains of PE via 
a hydrophobic cave (Osawa et al., 2019) (Diagram 1.2B). Moreover, Atg2 lipid transfer was 
bidirectional and happens through concentration gradients without ATP hydrolysis, and the 
WIPI4 tethering does not determine the direction of transfer (Maeda et al., 2019). The N-tip of 
the ATG2 has been found able to localize to the ER, raising a possibility that ATG2 extracts 
lipids from ER to newly formed isolation membranes. 
In contrast to the ‘Bridge’ model, an alternative ‘ferry model’ was presented based on the 
following two observations (Diagram 1.3.C). First, when anchored onto the donor membrane, 
aa 1-345 of ATG2A is capable to mediate lipid transfer in vitro without WIPI4, and this truncated 
form can rescue the autophagy defect in an ATG2A/B knockout cell line (Valverde et al., 2019). 
Second, ATG2A can bind to only one liposome and two liposomes simultaneously (Chowdhury 
et al., 2018). Therefore, lipid transfer is suggested to be facilitated by shuttling of the N-tip 
fragment (aa 1-345) of ATG2 and is not dependent on tethering of donor and acceptor 
membranes.  
  





1.1.1.4 Autophagosome closure 
The mechanism of autophagosome closure is poorly understood, although topologically it is 
supposed to be a constriction of a hole followed by fission of the inner and outer membrane 
conjunction sites (Dimova et al., 2015), which is similar to how ESCRTs drive membrane 
fission at multivesicular bodies (MVBs). Given the limitations of light microscopy, the fission-
dependent separation of inner and outer membranes cannot be resolved by live imaging 
currently. The machinery used by this process is uncertain, although clues are pointing to 
ESCRT complexes or ATG8 proteins. 
1.1.1.4.1 ESCRT 
ESCRT is a set of conserved complexes—0, I, II, and III—and many accessory proteins (e.g., 
the Vps4 ATPase), functioning downstream of Rab5. ESCRT was initially been found to 
mediate scission on multivesicular bodies (MVBs) in yeast. The cytosolic ESCRT complexes 
cluster ubiquitinated proteins on endosomal membranes to specific membrane domains, 
constrict these domains and catalyze pinching off vesicles containing these domains into the 
lumen of the endosome (Henne et al., 2013). It also mediates topologically similar membrane 
constriction and abscission in the plasma membrane (PM), abscission during cytokinesis and 
PM repair, exosome and microvesicle shedding and viral release from the PM (Adell et al., 
2016; Christ et al., 2017).  
The yeast ESCRT III subunits Snf7 and the Vps4 ATPase catalyze autophagosome closure in 
yeast (Yoshinori et al., 2018). The recruitment of Snf7 and Vps4 to phagophores is dependent 
on the Rab5 GTPase Vps21, possibly through enabling the interaction between Snf7 and 
Atg17/Atg11/Atg29 complex (Zhou et al., 2019). Atg17 stays on autophagosomes until after 
closure. Although the mammalian homolog of Snf7, CHMP4B, has not been investigated, 
another subunit of mammalian ESCRTIII named CHMP2A regulates the abscission of the inner 
and outer autophagosomal membranes together with AAA-ATPase VPS4 (Takahashi 2018). 
Consistently, RAB5 is dispensable for autophagosome-lysosome fusion but required for the 
autophagosome closure (Hegedűs et al., 2016). 
The SNARE complex locates in the outside corner of two contacting membranes and reducing 
the angle of the corner, while ESCRTIII locates inside the membrane neck with the ATPase 
VPS4 tightening the CHMP2A-CHMP3 spiral to reduce the diameter of the neck (Maity et al., 
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2019) (Diagram 1.4). Therefore, ESCRTIII fits the topological requirement for autophagosome 
closure machinery. 
1.1.1.4.2 ATG8 family proteins 
Atg8 family proteins are ubiquitin-like proteins, consisting of two amino-terminal α helices and 
a ubiquitin-like core. There is only one Atg8 protein in the yeast, but multiple homolog genes 
in C.elegans (LGG-1, LGG-2) and mammals. The C.elegans LGG-2 is the ortholog of 
mammalian microtubule-associated protein 1 light chain 3 (MAP1LC3, hereafter referred to as 
LC3) subfamily proteins LC3A, LC3B and LC3C, while LGG-1 is the ortholog of mammalian γ-
aminobutyric acid receptor-associated protein (GABARAP) subfamily proteins (GABARAP, 
GABARAPL1 and Golgi-associated ATPase enhancer of 16 kDa (GATE-16)) (reviewed in 
Shpilka & Elazar et al., 2011). LGG-2 is required for the degradation of LGG-1 positive vesicles, 
suggesting that mammalian GABARAPs may function downstream of LC3 family proteins (Wu 
et al., 2015). 
ATG8-deleted cells are defective of delivery to the lysosome and expansion, but can still 
complete the closure of autophagosomes by membrane fission (Nguyen et al., 2016), albeit 
with significantly longer time (6 hours versus < 2 hours). Nguyen and his colleagues also 
showed by the Proteinase K protection assay that GABARAP family and ATG8 family knockout 
HeLa cells only have closure defect in basal conditions, but not in BafA1 plus starvation 
conditions.  
It was then hypothesized that fission in autophagosome closure is a subtle morphological 
change (Tsuboyama et al., 2016). Elliptical starvation-induced phagophores suddenly become 
spherical at a very late stage of maturation. In ATG3 KO MEF cells, this conversion occurred 
much more slowly, even reverting to fully open ‘cups’ in extreme cases. Moreover, STX17 and 
Lysotracker red (LTR) were used to label uncompleted/ unclosed autophagosomes. LTR labels 
lysosome materials and shows ring-shape when the inner membrane of autophagosome is not 
broken down, while STX17 labels the outer membrane of autophagosomes. With this assay, it 
was found that the breakdown of the inner membrane only happens after the autophagosome 
is completed. It was also observed that the STX17 positive-LTR ring-shaped structures were 
maintained for a much longer period (>30 min versus 11 min) in ATG3 knockout (KO), ATG5 
KO, and ATG7 KO MEFs compared with WT and rescued ATG3 KO MEFs. Consistent with 
Nguyen et al., Tsuboyama’s observation also suggests that ATG8 is not absolutely required 
for fission. Notably, ATG3-ATG12 complex also functions at the late stage of autophagosome 
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formation, and ATG3 interacts with ESCRT (Murrow et al., 2015). Therefore, there is a 
possibility that ATG3 accelerates closure partially through the ESCRT complex.  
The tethering of the phagophore edge may similarly promote autophagosome closure, raising 
the possibility that the mechanism of ATG8 proteins in accelerating closure is through 
membrane tethering. There has been numerous biophysical evidence supporting that ATG8 
family proteins regulate membrane tethering (reviewed in Nakatogawa et al., 2007). Moreover, 
GABARAPs may form homo-oligomers (Coyle et al., 2002), raising the possibility that they 
may have open/close structures and bind each other on the target membrane to bridge two 
membranes. Although no significant conformational dynamism of one single GABARAP 
protein has been found (Ma et al., 2010), it was found in C.elegans that the closed or open 
conformation is isoform-specific (Wu et al., 2015). However, the role of the ATG8 proteins in 
tethering may also depend on the distance of the two membranes, because the ATG8 bridge 
is less than ~10 nm (~4 nm from each Atg8 protein) (Yu & Melia, 2017). 
Moreover, there are a few studies about LC3 and GATE-16 mediating full membrane fusion in 
vitro (Weidberg et al., 2011). The mechanism is engaging lipids with their amino termini with 
either hydrophobic or electrostatic interactions (Weidberg et al., 2011). The required 
sequences identified in these in vitro studies are also required in vivo. However, most tethers 
cannot fuse the membranes with rare exceptions, including MFN1/2 (Eisenberg-Bord et al., 
2016). Generally, tethering proteins cannot bring the opposing membranes to the distance 
required for fusion (a few angstroms), nor can they generate mechanical forces to overcome 
the energy barrier of 2 hydrated lipid bilayers opposing each other when they are that close. 
Consistent with the above hypothesis, no lipid mix mediated by ATG8 were observed when 
using stable lipid mixtures (Jotwani et al., 2012), nor when membranes are not of high 
curvature in vitro (Romanov et al., 2012). Therefore, it seems that ATG8 mediated fusion 
requires unstable/ highly curved membranes. However, it is unknown how unstable/ curved 
the edges of phagophores are in vivo and whether the in vitro reconstitution experiments 
lowered the energy barrier to lower than the physiological status. Thus, the in vitro evidence is 
not conclusive about whether ATG8s mediate membrane fusion directly or indirectly, and it is 
unknown how ATG8s accelerate autophagosome closure. 
1.1.1.4.3 The other regulators of closure 
WIPI4-ATG2 complex 
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Unclosed autophagosome-related membranes accumulated in ATG2-depleted cells 
(Velikkakath et al., 2012). However, another observation by EM suggests that the 
autophagosomes were still closed in ATG2 depleted cells (Tang et al., 2019). Moreover, 
proteinase K treatment can reverse the increase of liposome size facilitated by Atg2, 
suggesting that Atg2 cannot fuse membrane (Osawa et al., 2019). Therefore, ATG2 may 
indirectly affect closure through regulating the expansion, similar to ATG8. For example, ATG2 
may recruit closure machinery from other organelles or vesicles through mediating lipid 
transfer.  
TRAPPC11 is one of three components of the TRAPIII complex, which can capture vesicles 
by tethering or bridging two membranes (~50–100 nm) (Bröcker et al., 2010) and functions in 
ER-Golgi trafficking.  In mammalian cells, TRAPPC11 recruits the ATG2-WIPI4 complex onto 
phagophores depending on ATG9 function, and its loss of function causes an autophagosome-
closure defect (Stanga et al., 2019). However, the other two subunits of TRAPIII: TRAPPC12 
and TRAPPC8, do not seem to have similar functions in the closure process, possibly due to 
having different interacting partners.  
ATG9 
TRAPIII also regulates ATG9 retrieval from recycling endosomes to the Golgi (Rao et al., 
2016). In addition, excess sphingomyelin leads to accumulation of ATG9 in transferrin 
receptor-positive juxtanuclear recycling endosomes (Corcelle-Termeau et al., 2016) and 
impairs autophagosome degradation. EM showed that excess sphingomyelin causes 
accumulation of unclosed autophagosomes, and this can be rescued by the recovery of ATG9 
trafficking.  
WIPI4-ATG2 complex and ATG9 vesicles both function in autophagosome expansion, but it is 
unknown whether they regulate each other’s function. Yeast Atg2-Atg18 complex has been 
reported to mediate the retrieval of Atg9 from the PAS to the peripheral region. And the 
interaction of Atg2 with Atg9 is required for Atg2 confinement to the growing phagophore 
extremities and subsequent association of Atg18. Atg2–Atg18 association was severely 
affected in the absence of Atg9 (Gómez-Sánchez et al., 2018). Mammalian ATG9 is required 
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for the recruitment of ATG2-WIPI4 complex onto phagophores (Stanga et al., 2019). It is 
unknown whether WIPI4/3 or WIPI1/2 are relevant to ATG9 trafficking in mammalian cells. 
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ATG4 
Ultrastructural analysis of Atg4B-C74A-overexpressing cells showed that the ratio of the 
number of open autophagosomes versus closed autophagosomes increased by 20% 
compared to the empty vector transfected cells. Additionally, the size of closed 
autophagosomes decreased by 15% (Fujita et al., 2008). The Atg4B mutant sequesters LC3 
paralogues and blocks the formation of the Atg7-LC3 intermediate (Fujita et al., 2009). 
However, it is unknown whether the ATG4B mutant impairs closure through defective ATG8 
lipidation, and it is also unknown how defective lipidation can affect closure. 
1.1.1.5 Endosomal/lysosomal fusion 
Autophagosomes fuse either directly with lysosomes to form autolysosomes, or with 
endosomes to form amphisomes (Klionsky, 2007; Lucocq & Walker, 1997). Membrane fusion 
is regulated by fusion and tethering protein complexes, lipid metabolism and local cytosolic 
levels of calcium ions, and actin organisation (reviewed in Corona & Jackson, 2018). SNAREs 
and tethering factors are most representative modulators of endosomal/lysosomal fusion. 
1.1.1.5.1 SNARE proteins 
SNAREs are responsible for the physical fusion of the lysosome and 
autophagosome/amphisome membranes. The general mechanism is that the Q-SNAREs form 
a receptor complex on the target membrane first, awaiting R-SNARE-laden vesicles to bind to 
them (reviewed in Lou et al., 2016). The core SNAREs that regulate the autophagy pathway 
are Syntaxin 17 (STX17) or YKT6 on autophagosomes, vesicle-associated membrane protein 
8 (VAMP8) on lysosomes, and Synaptosome associated protein 29 (SNAP29), which facilitate 
their binding (Itakura et al., 2012; Matsui et al., 2018). STX17 is a Qa-SNARE, and its 
localization is regulated by LAMP2 (Huber et al., 2016), LC3/GABARAP proteins (Itakura et 
al., 2012), and IRGM (Kumar et al., 2018). STX17 and YKT6 are collectively required for 
autophagosome-lysosome fusion. SNAP29 is a promiscuous, non-lipid anchored Qbc-SNARE 
(Diagram 1.4) that donates two coiled-coil domains to the forming SNARE bundle (Hohenstein 
et al., 2001). There are some other SNAREs regulating specific types of fusion events in 
autophagy.  Autophagosomes recruit diverse SNAREs depending upon their ultimate fate 
(Kimura et al., 2017). SNAREs also play a role in determining the specificity of vesicles and 
target membranes (Sudhof et al., 2009).  
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1.1.1.5.2 HOPS complex 
The homotypic fusion and protein sorting complex (HOPS) is an evolutionarily conserved 
membrane tethering complex for membranes containing the RAB7 GTPase. It tethers Rab7 
positive membranes with autophagosomes through interaction with ATG8 family members. 
HOPS interacts with STX17 (Jiang et al., 2014) and also primes the core SNARE bundle 
assembly (Orr et al., 2017). PLEKHM1 promotes fusion indirectly by interacting with the HOPS 
complex. The switch of GTPases from RAB5 to RAB7 is also required for autophagosome-
lysosome fusion (Hegedus et al., 2014).  
1.1.1.5.3 GABARAP is a HOPS regulator 
C18orf8/RMC1, a new subunit of the CCZ1-MON1 RAB7 guanine exchange factor (GEF) that 
positively regulates RAB7 recruitment to late endosomes/autophagosomes, was found to 
accumulate in GABARAP/L1/L2-deficient cells (Vaites et al., 2018), suggesting that GABARAP 
may be required for its sorting to lysosomes. The authors also found that RMC1 loss of function 
impairs autophagosome maturation, but did not assess whether it was a closure or fusion 
defect. BRUCE, which specifically interacts with GABARAP but not LC3, regulates the delivery 
to lysosomes through HOPS (Ebner et al., 2018). In C. elegans, GABARAP also directly 
interacts with VPS39, a subunit of HOPS complex and regulates autolysosome formation 
(Manil-Ségalen et al., 2014).  
1.1.1.5.4 Other HOPS/ SNARE regulators  
Many other fusion regulators function through interaction with the HOPS complex or SNAREs. 
The Atg17-ATG29 complex modulates autophagosome-lysosome fusion by interacting with a 
vacuolar SNARE Vam7 independently of each other (Liu et al., 2016). Atg17 also regulates 
autophagosome formation during stress-induced autophagy (Davies et al., 2015).  
1.1.1.5.5 Lipids 
Dysregulation of lipids inhibits fusion directly or indirectly through the proteins they associate 
with. Removal of certain Atgs (Noda et al., 2009) after closure is also required for fusion, 
possibly by inhibiting the recruitment of fusion factors. Depletion of Ymr1 PI3P phosphatase 
accumulated sealed autophagosomes with Atgs on them (Cebollero 2012). 
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A decrease or accumulation of lysosomal cholesterol changes the fluidity of the membrane 
and inhibits fusion (Fraldi 2010).  The presence of PI(4)P on autophagosomes (Wang et al., 
2015) and a correct balance of PI(3,5)P2: PI(3)P (Hasegawa et al., 2016) are both required for 
delivery of autophagic content to lysosomes.  
1.1.1.5.6 Microtubules and motor proteins 
The positioning of lysosomes affects their membrane fusion with autophagosomes. Dynein 
(Ishikawa, 2012) associates with lysosomes in a dynactin-dependent manner to regulate 
lysosomal positioning and thereby the fusion with autophagosomes. Mature autophagosomes 
move along acetylated stable microtubules resistant to destabilizing nocodazole treatment, 
and the organisation of unacetylated microtubules does not affect the fusion. However, either 
nocodazole or microtubule-stabilizing paclitaxel treatment impairs the conversion of LC3-I to 
LC3-II (Xie et al., 2010), suggesting that microtubules are involved in some way in 
autophagosome formation. 
1.1.1.6 Autolysosome degradation 
Lysosome acidification is not required for regulation of membrane fusion but is required for the 
degradation of autolysosomes. The V-ATPase on lysosomes acidifies the lysosome lumen 
through ATP-hydrolysis and proton-pumping (Kane, 2006). The low pH stimulates the activity 
of lysosomal hydrolases for efficient degradation of autophagy substrates (Peri and Nusslein-
Volhard, 2008). However, its proton translocation activity is not required for membrane fusion. 
The proton pump activity of V-ATPases can be inhibited by bafilomycin A and concanamycin 
A (Bowman and Bowman, 2000; Huss et al., 2002).  
Cathepsin activity and maturation are used as markers of lysosome function. Cathepsin family 
proteins are endopeptidases. Cathepsin D is synthesized in rough ER as preprocathepsin D. 
After removal of the signal peptide, the 52 kDa procathepsinD is targeted to endo-lysosomes 
and phagosomes. Upon entering acidic compartments, the 44 amino acid N-terminal 
propeptide is removed and a 48 kDa single-chain intermediate forms. Further proteolytic 
cleavage yields the mature form composed of heavy (34 kDa) and light (14 kDa) chains, which 
are linked by non-covalent interactions (Benes et al., 2009).  
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1.1.2 Cargo selection 
Autophagy can be either selective or non-selective in response to different stimuli. Almost 20 
selective autophagy pathways have been described, including autophagic processes 
responsible for the clearance of damaged organelles like mitochondria - mitophagy, 
peroxisomes - pexophagy; aggregate-prone proteins - aggrephagy; and pathogens - 
xenophagy (reviewed in Frake et al., 2015). The specificity of selective autophagy can be 
mediated by autophagy adaptors and receptors which recognize cargos and bind to ATG8 
family proteins (Stolz 2014). 
1.1.2.1 AIM-LDS interface 
Most known autophagy adaptors interact with ATG8 through their ATG8-interacting motif (AIM, 
or LC3-interacting region (LIR)). AIM/LIR binds to a hydrophobic patch (LDS) on ATG8.  
In yeast, Atg39 regulates the degradation of the perinuclear ER/nucleus under nitrogen-
deprivation conditions. Atg40, the yeast homolog of FAM134B, is a receptor for ERphagy 
(Mochida et al., 2015). 
Nuclear receptor coactivator 4 (NCOA4) is the cargo receptor for ferritin during ferritinophagy 
in mammalian cells (Dowdle et al., 2014). After internalization with transferrin, iron may either 
be transported to specific target proteins by chaperones, enter the mitochondrial matrix 
through mitoferrin 1 or mitoferrin 2, or become stored in the cytosol by binding to ferritin. Iron 
stored within cytosolic ferritin can be released during lysosomal degradation or proteasome 
degradation.  The delivery of iron to the mitochondria relies on the lysosomal degradation of 
ferritin. NCOA4 binds to ferritin and targets it to lysosomes through the autophagy pathway. 
Iron accumulation has been seen in some neurons that are the brain’s iron reservoir, storing 
iron in the form of ferritin, as the blood-brain barrier limits some forms of iron from entering the 
brain. Iron chelators have been used to treat some other neurodegenerative diseases, 
including Parkinson’s disease. However, excess degradation of ferritin induces ferroptosis by 
releasing chelated iron, which is subsequently transported back into the cytosol to induce 
oxidative stress (Kang et al., 2017). 
Nearly half of the selective autophagy pathways identified to date are ubiquitin-driven. 
P62/SQSTM1, NDP52, NBR1, OPTN and TAXBP1 mediate the degradation of ubiquitinated 
cargos including mitochondria; they preferentially bind to linear and K63-linked chains and 
mono-ubiquitin compared to K48-linked chains (Wurzer et al., 2015).  
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1.1.2.2 UIM-UDS interface 
Recently, a new class of ATG8 interactors was reported to exploit ubiquitin-interacting motif 
(UIM)-like sequences for binding to an alternative site on ATG8, named the ubiquitin-docking 
site (UDS).  UIM-based ATG8 interactors play a role in clearing non-functional CDC48/p97 
complexes, including some impaired in human disease.  
Six proteins were found to be UIM containing adaptors. Of these, four (Epsin (EPN)-1, EPN2, 
EPN3, and Rabenosyn (RBSN)) interacted with both ATG8 isoforms, whereas two (Ataxin 
(ATXN)-3 and ATXN3L) interacted only with GABARAP (Marshall et al., 2019).  
The preference of ubiquitin pathway players towards GABARAP has been reported before. 
Parkin-dependent mitophagy strongly relies on GABARAP dependent flux (Nguyen et al., 
2016). GABARAP is more prone to proteasome degradation (Rasmussen et al., 2017). 
GABARAP may be more tightly regulated than LC3 due to its extra roles in vesicle trafficking. 
For example, GABARAP transports GABAA receptors to the plasma membrane (PM) in 
neurons although itself is not present on the PM, and is required for early secretory pathway 
(Leil et al., 2004). GABAA receptors are anionic channels that carry gamma-aminobutyric acid 
(GABA), which is the main inhibitory neurotransmitter in the adult central nervous system 
(Lester et al., 2004). 
1.1.3 Autophagy and diseases 
Autophagy dysfunction is implicated in neurodegeneration, metabolic diseases, cancer and 
infectious disease in varying roles (reviewed in Menzies, 2017 and Jiang et al., 2014).  
1.1.3.1 Neurodegeneration diseases 
Many genes are implicated in neurodegenerative diseases. For example, phosphatase and 
tensin homolog-induced putative kinase 1 (PINK1) (Valente et al., 2004) and the E3 ubiquitin 
ligase Parkin (Kitada et al., 1998), which are involved in mitophagy, are associated with 
autosomal recessive forms of Parkinson’s Disease (PD). Mice with some core autophagy 
genes knocked out by the Nestin-Cre promoter embryonically all show early on-set 
neurodegeneration in the brain in neuronal precursor cells. These genes include ATG5, ATG7, 
FIP200, WIPI4 and ULK1/2 (reviewed in Menzies et al., 2017). Stimulation of autophagy by 
Beclin-1 overexpression reduces aggregates and reverted memory deficits in AD mice (Barnett 
and Brewer et al., 2011). Generally, autophagy is cytoprotective in neurodegenerative 
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diseases although amyloid β (Aβ), which forms plaques extracellularly in Alzheimer’s Disease 
(AD), seems to be both degraded (Boland et al., 2008) as well as generated and secreted by 
autophagy (Yu et al., 2005; Nilsson et al., 2013). 
1.1.3.1.1 BPAN 
De novo mutations in WIPI4 were found to be causative for static encephalopathy in childhood 
with neurodegeneration in adulthood (SENDA), also known as BPAN (beta-propeller protein-
associated neurodegeneration). SENDA or BPAN is an X-linked dominant subtype of 
neurodegeneration with iron accumulation (NBIA), a heterogeneous disorder characterized by 
neurological movement disorder and progressive degeneration of the nervous system (Saitsu 
et al., 2013). Iron deposition in the substantia nigra (SN) and globus pallidus (GP) is a 
diagnostic marker for BPAN but only becomes evident some years after disease onset, so the 
diagnosis of this disease is often quite late (Russo et al., 2018).  
In lymphoblastoid cell lines derived from BPAN patients, mutations in WIPI4 result in truncated 
proteins that are prone-to-degradation, leading to lower amounts of protein compared to 
unaffected individuals. These cells showed impairment in autophagy flux and accumulation of 
LC3-positive autophagosome membranes that were also positive for ATG9 (Saitsu et al., 
2013). These observations provide evidence that autophagy defects due to WIPI4 depletion 
are associated with neurodegeneration in BPAN. CNS-specific Wdr45 knockout (Nes-
Wdr45fl/Y) mice generated by Zhao et al. recapitulate some phenotypes of BPAN, for example, 
impaired motor coordination, axon swelling and cognitive defects. Also, ubiquitin-positive 
protein aggregates and p62 accumulated in neurons and swollen axons of these mice, 
suggesting a blockage of autophagy flux. This model corroborates the link between the 
autophagy defect and pathogenesis of BPAN (Zhao et al., 2015). In addition to the link with 
BPAN, WIPI4 has been found to be overexpressed in pancreatic and kidney cancer samples 
(Proikas-Cezanne et al., 2004). 
1.1.3.1.2 Huntington’s disease and polyglutamine disorders 
Huntington’s disease (HD) belongs to a family of nine diseases caused by the expansion of 
cytosine-adenine-guanine (CAG) repeats in the coding region of genes. The CAG repeat 
expansions cause various effects depending on the gene context. Spinocerebellar ataxias 
(SCA) 1, 2, 3, 6, 7, 17 are caused by CAG repeat expansions in the Ataxin 1, 2, 3, 6, 7 and 
TBP genes and affect primarily the cerebellum and brainstem. Dentatorubralpallidoluysian 
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atrophy is related to the Atrophin 1 gene and affects the cerebellum as well as the cortex and 
midbrain (Nagafuchi et al., 1994; Zoghbi et al., 2000; Nagafuchi et al., 1994). Except for X-
linked spinobulbar muscular atrophy, which is related to the androgen receptor (Spada et al., 
1991), all are autosomal dominantly inherited. 
Huntingtin (Htt) codes for a 348 kDa protein with CAG repeats in its N-termini, which translates 
into a homomeric polyglutamine (polyQ) stretch. HD develops when the polyQ stretch exceeds 
a threshold of 36 glutamines, and its length is inversely proportional with the age of onset of 
the disease (Narain et al., 1999). Wild-type Huntingtin protein positively regulates selective 
autophagy in stress conditions by binding and releasing ULK1 from mTOR and facilitating the 
interaction of the adaptor protein p62 with LC3 (Rui et al., 2015). However, the dominant 
inheritance pattern and evidence in model animals suggest that the toxicity of mutant HTT, 
rather than the loss of wild type HTT, is the primary cause of the disease (Bates, 2003).  
Mutant HTT causes neurodegeneration by both PolyQ-HTT fibrils and intermediates/oligomers 
formed during the aggregation or degradation process (Sarkar et al., 2008). Although it is 
disputed whether polyglutamine expansion containing proteins including mutant-HTT, mutant 
ATXN-1, ATXN-3, impair the ubiquitin-proteasome pathway (Bence et al., 2001; Bennett et al., 
2007, Bett et al. 2006), the soluble form of mutant HTT is found to be degraded by the 
proteasome (de Pril et al., 2010), and UBR5 has recently been identified to target it to 
proteasomes in iPSCs derived from Huntingtin’s disease patients (Koyuncu et al., 2018).  In 
addition, the soluble huntingtin mutant protein is also toxic and competes with protective 
deubiquitinating enzyme Ataxin 3 for binding with Beclin-1, thereby inhibiting autophagy. In the 
brain samples from HD patients, Beclin-1 levels and LC3-II levels decreased (Ashkenazi et al., 
2017). 
1.1.3.2 Cancer 
The role of autophagy in metastatic progression is highly context-dependent. On the one hand, 
autophagy may decrease migration and inhibit cell cycle progression. FAK and SRC, key 
regulators of focal adhesion dynamics, are both regulated by autophagy (Abbi et al., 2002; 
Sandilands et al., 2011). On the other hand, autophagy may increase the viability of cancer 
cells and promote tumour progression. Deletion of ATG7 in K-rasG12D-driven tumours causes 
shrinkage of the tumour (Xie et al., 2015). Arginine recycling facilitated by autophagy maintains 
tumor (Poillet-Perez et al., 2018). 
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1.2 Ubiquitination-proteasome system 
1.2.1 Machinery 
1.2.1.1 The ligase cascade 
Ubiquitination is the covalent attachment of ubiquitin onto proteins to signal for proteasome 
degradation and other proteasome-independent processes including signalling, translocation, 
activation/ inactivation. The conjugation of ubiquitin is a cascade event that involves three 
ligases: E1, ubiquitin-activating enzyme; E2, ubiquitin-conjugating enzyme; and E3, ubiquitin 
ligases (Hershko et al., 1996). 
E1 forms a thioester bond with the C-terminal glycine of ubiquitin in an ATP-dependent 
manner. The E1-ubiquitin conjugate is then transferred onto the activating cysteine of E2. The 
catalytic cysteine on the E3 enzyme can receive ubiquitin from the E2 and then conjugate it 
onto the substrate proteins (Hershko et al., 1983).  
Each of the seven lysine residues on ubiquitin molecules and the N-terminal methionine 
residue (M1) can be linked with one or more ubiquitin molecules. The composition, including 
mono- or multi-Ub and the exact Ub chain, determines whether the protein is going to be 
degraded, and which signalling pathway the substrate protein may function in. Substrate-
conjugated ubiquitin can be further modified by other post-transcriptional modifications, such 
as phosphorylation, and acetylation, further complicating the signalling of ubiquitination. 
K48 poly-ubiquitination is the most abundant linkage type and usually signals for delivery to 
the proteasome for degradation (Rotin and Kumar, 2009). K11 and K27 linked ubiquitin chains 
also label their substrate for proteasome degradation. The K11-K48 branched-chain modulates 
proteasome degradation of misfolded nascent proteins and mitotic regulators (Collins et al., 
2017). 
K63-linked ubiquitination is the second most abundant type. Homogeneous K63 chains 
regulate signal transduction, endocytosis (Komander et al., 2012) and have an affinity for 
autophagy adaptors and receptors (Linares et al., 2013). K63 chains seeded with branched 
ubiquitin chains can trigger proteasomal degradation (Ohtake 2018). 
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Other types of lysine ubiquitination, as well as their associated function(s), are K6 (involved in 
DNA repair), K29 (lysosomal degradation, kinase modification) and K33 (kinase modification 
(Komander, 2009).  
The linkages between ubiquitin molecules themselves and between ubiquitin molecules and 
their substrates can be hydrolyzed by deubiquitinating enzymes (DUBs) (de Poot et al., 2017), 
and therefore, ubiquitination is a reversible process. 
1.2.1.2 The 26S proteasome  
The 26S proteasome is made of the core barrel-like structure 20S proteasome and the 19S 
capping proteins at either end. The latter are responsible for recognising and binding of 
substrates (or ubiquitin receptor shuttling), deubiquitination, substrate unfolding and 
translocation onto the 20S core (Livneh et al., 2016). The proteasome substrates are degraded 
by three enzymatic mechanisms of action (trypsin-like, chymotrypsin-like and caspase-like) 
(Grice and Nathan, 2016).   
Because of the barrel structure of the core 20S subunit, proteasome subunits need to be 
unfolded into peptide chains before entering. Therefore, aggregated proteins and oligomers 
are considered resistant to degradation by the proteasome (Verhoef et al., 2002).  
1.2.2 N-end rule 
1.2.2.1 Machinery and function 
It has been found that the single N-terminal (Nt) residue of a protein is related to the in vivo 
half-life of the protein (Bachmair et al., 1989). In eukaryotes, substrate proteins with specific 
N-terminal residues are recognized by UBR-box-containing E3 ubiquitin ligases and delivered 
for proteasome degradation. Sometimes, additional post-transcriptional modification is 
required for this recognition. This destabilization of a protein by posttranslational modification 
of the N-terminal residues was named the ‘N-end rule’ (Sriram et al., 2011; Varshavsky, 2011), 
and the destabilizing N-termini residues are referred to as ‘N-degrons’. 
In mammalian cells, unacetylated Nt-residues are targeted by Arg/N-degron pathway. The N-
degrons of this pathway are classified into Type 1 and Type 2 (Diagram 1.5):  
Type 1: positively charged, include Arg, Lys, and His. 
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Type 2: bulky hydrophobic, include Phe, Tyr, Trp, Leu, and Ile. 
The major and strongest of them is Nt-Arg, which can also be generated by the conjugation of 
the amino acid L-Arg to Nt-Asp or Nt-Glu by R-transferase ATE1. Arginylation also occurs on 
Nt-Asn, Nt-Gln, and Nt-Cys following Nt-post-translational modifications. The residues that can 
be arginylated are called secondary or tertiary N-degrons. For example, regulators of G protein 
signaling RGS4 and RGS5, which have Nt-Cys, undergo ATE1 catalysed arginylation on its 
oxidized Nt-Cysteine and are then degraded by UBR1 and UBR2 (White et al., 2017; Lee et 
al., 2005). Hypoxia perturbs the proteolysis of RGS4 and RGS5 by inhibition of the oxidation 
of Nt-Cys.  
The N-degrons first need to be exposed by aminopeptidase-mediated removal of the N-
terminal methionine. Methionine aminopeptidase 1 and 2 in mammalian cells remove the Nt-
Met efficiently when the penultimate amino acid has a side chain smaller than Valine’s in both 
prokaryotes and eukaryotes, although there are a lot of variations regarding different species. 
Also, the glutamyl-aminopeptidase and leucine aminopeptidase cleave Nt-Methionine when 
the penultimate amino acid is lysine in M. hyopneumoniae (Berry et al., 2017).   
In mammalian cells, UBR1, UBR2, UBR4 and UBR5 recognise Arg/N-degrons through their 
UBR domains (reviewed in (Kim et al., 2013)) and are named as ‘N-recognins’. Only UBR5 
preferentially binds type 1 N-degrons (Tasaki et al. 2009).  Recently, p62 was found to bind 
Arg/N-degrons through its ZZ domain, but it is not an E3 ligase (Yoo et al., 2018). An N-
recognin can contain several degron-recognizing sites, suggesting that an N-recognin-E3 
ligase can bind not only to N-degrons but also to internal degradation signals in proteins that 
lack an N-degron (Varshavsky et al., 2011). 
The substrate-selection of N-recognins requires multistep interactions. First, the UBR box of 
the E3 ligase forms transient and reversible hydrogen bonds with the free α-amino group of 
the N-degron. Second, the UBR box forms hydrogen bonds with the positively charged side 
chains in type 1 degrons and the bulky hydrophobic side chains in type 2 degrons. In a type 1 
interaction, these hydrogen bonds are stabilized by a salt bridge formed between the 
negatively charged surface of the UBR box and a positively charged N-terminal side chain. 
Third, after the N-recognin binds the N-terminal residue, the side chain of the second residue 
may further support the interaction, whereas the side chain at position three is located away 
from the surface of the binding groove (Choi et al., 2010), restricting the major interactions to 
the first two residues. 
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The function of the Arg/N-Degron pathway is not limited to degradation. It can also transport a 
substrate that has a destabilizing Nt-residue but lacks an efficacious second-determinant 
lysine (Turner et al., 2000). With a similar mechanism, an Arg/N-recognin could 
polyubiquitylate in trans another subunit of the same complex, or, in other words, bind to one 
N-degron containing subunit but degrade another subunit with internal degrons (Johnson et 
al., 1990). 
Two other N-end rule pathways, the Ac/N-degron (Hwang et al., 2010) and Pro/N-Degron 
(Chen et al., 2017) pathways targeting acetylated and N-terminal-Proline substrates 
respectively, have been identified recently. 
 
1.2.2.2 UBR5, a representative E3 ligase of the N-end rule pathway 
1.2.2.2.1 UBR5 structure 
UBR5 (309kDa) is predicted to have four domains and two nuclear localization sequences as 
shown in Diagram 1.6: Ubiquitin associated (UBA) domain, Ubiquitin Recognin Box (UBR), 
domain homologous to C-terminus of Poly-Adenylation Binding Protein (PABC, also called 
MLLE), and homologous to E6-AP C terminus (HECT) domain. There are also two nuclear 
localization sequences (NLSs) in UBR5 (reviewed in (Shearer et al., 2015)). 
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The UBA domain binds to ubiquitin and has no strong preference for binding to polyubiquitin 
chains over monoubiquitin (Kozlov et al., 2007), and therefore may be involved in protein-
protein interaction. The UBR domain is a zinc finger-like domain involved in recognition of type 
1 N-degrons. PABC (MLLE) domain is predicted to interact with RNA and Paip1/2 (Kozlov et 
al., 2004; Lim et al., 2006), facilitating UBR5’s function in mRNA translation. It also regulates 
the catalytic activity of UBR5 by binding onto the catalytic HECT domain and inhibiting its 
binding to substrates (Munoz-Escobar et al., 2015). 
 
1.2.2.2.2 UBR5 function 
UBR5 assembles K48/K63 branched linkages on K63-ubiquitinated TXNIP (Ohtake 2018). 
UBR4 and UBR5 regulate quality control for the synthesis of K11/K48 branched chains during 
proteotoxic stress, with UBR5 generating K48 linkage from the initially mixed conjugates (Yau 
et al., 2017). UBR5 binds K63-linked diubiquitin more strongly than ubiquitin monomers or 
K48-linked diubiquitin with its UBA domain (Ohtake 2018) and can possibly bind to working 
ribosomes with its RNA binding domain (Yau et al., 2017). Altogether, UBR5 seems to regulate 
heterotypic/branched chains in different contexts, presumably in collaboration with different 
E3s. 
UBR5 negatively regulates double-stranded break repair of DNA by counteracting excessive 
spreading of ubiquitin conjugates and ubiquitin-regulated genome caretakers to undamaged 
chromosomes. UBR5 inhibits the K63-linked polyubiquitination of histone H2A by degrading 
RNF168 (Gudjonsson, 2012). Lysine-63-linked ubiquitin polymers on H2A and H2AX generate 
an interaction platform for chromatin-associated repair and signalling factors, including 53BP1 
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and the RAP80/BRCA1 complex (Bothmer et al., 2010 & 2011; Bouwman et al., 2010; Bunting 
et al., 2010; Coleman and Greenberg, 2011; Hu et al., 2011). In addition, UBR5 generates K48 
ubiquitination of Groucho/TLE, a repressor of the Wnt enhanceosome. The ubiquitination of 
Groucho/TLE stabilizes β-catenin, which relieves chromatin compaction and stimulates the 
Wnt pathway (Flack et al., 2017). 
To summarize, UBR5 has been found to regulate mRNA translation and quality control of 
proteins, as well as to inhibit excessive DNA repair and induce Wnt signalling. 
1.2.2.2.3 Disease implications of UBR5 
Neurodegenerative diseases 
c.5720G>A mutation (p.Arg1907His) in the UBR5 gene was found to be associated with 
familial adult myoclonic epilepsy (FAME) in a Japanese FAME family (Kato et al., 2012) but no 
additional mutation in UBR5 was found in other pedigrees (van Rootselaar et al., 2017).  FAME 
usually starts in the second decade of life and has been genetically associated with 4 different 
loci (8q24, 2p11.1-q12.2, 5p15.31-p15 and 3q26.32−3q28) (Lagorio et al., 2019). It is slowly 
progressive with intellectual decline and worsening of both tremor and myoclonus.   
In addition, UBR5 has been found to promote the degradation of mutant HTT aggregates in 
iPSCs from HD patients (Koyuncu et al., 2018). 
Cancer 
UBR5 is involved in various areas of cancer biology, such as regulation of DNA damage 
(Zhang et al., 2014), metabolism (Jiang et al., 2011), transcription (Ong et al., 2014), and 
apoptosis (Henderson et al., 2006). Although it is unclear whether UBR5 promotes or inhibits 
tumour progression, presumably depend on context (Shearer et al., 2015), UBR5 amplification 
is the predominant genetic alteration in many types of cancers (far more prevalent than loss-
of-function UBR5 mutations), and amplified UBR5 correlates with poor outcomes in breast 
cancer (Shearer et al., 2015).  
1.3 Crosstalk between autophagy and proteasome pathways 
The autophagy and the ubiquitin-proteasome system mutually regulate each other.  
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1.3.1 Selective autophagy degradation of ubiquitinated substrates 
As discussed before, autophagy pathways degrade ubiquitination substrates through adaptors 
or receptors. Although most of them recognize K63 linked chains, both K48 and K63-linked 
ubiquitination substrates can be degraded by autophagy. For example, BAG3 delivers K48-
linked ubiquitinated proteins to lysosomes through directly binding to K-48 and p62 (Rosati et 
al., 2011) in aggrephagy.  Consistently, all ubiquitin chain types have been found enriched in 
the insoluble inclusions of autophagy-deficient mice (Riley et al., 2010). 
1.3.2 The ubiquitin-proteasome system both induces and inhibits autophagy 
Given the central role of ULK1 and PI3K–III kinase complexes in autophagy induction, the 
ubiquitination signals on these complexes indicate that autophagy is also regulated by the 
ubiquitin-proteasome system. 
1.3.2.1 K63-ubiquitination induces autophagy 
TRAF6 ubiquitinates ULK1 with the assistance of AMBRA1 by K63-linked chains, which 
promotes the self-association of ULK1 and thereby autophagy induction (Yeh et al., 2011; 
Nazio et al., 2013). BECLIN 1 is also a substrate of TRAF6 (Shi et al., 2010). The K63 and 
K117 ubiquitination on BECLIN inhibits its binding with BCL2, thereby inducing autophagy.  
1.3.2.2 Degradative ubiquitination regulates autophagy termination 
BECN 1 is ubiquitinated and degraded by the HECT-type E3 ligase through NEDD4 Lys-11-
linked chains (Platta et al., 2012). ULK1 is degraded by NEDD4L, an E3 ligase highly 
homologous to NEDD4, via K27 and K29-linked polyubiquitination (Nazio et al., 2016). Another 
E3 ligase, CULLIN3–KHLH20, degrades ULK1, BECLIN 1, and VPS34 via K48 poly-Ub chains 
(Liu et al., 2016). In addition to E3 ligases, the wild-type ataxin 3 protects BECN 1 from 
proteasome-mediated degradation by its deubiquitination activity (Ashkenazi et al., 2017).  
Altogether, the proteasome pathway may regulate the induction and termination of autophagy, 
either by modulating their protein levels or through activation by K63-linked ubiquitination 
(reviewed in Dikic et al., 2018).  
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1.4 Objectives 
WIPI4 degradative mutations are the only causative mutations in BPAN diseases. In 
lymphoblastoid cell lines derived from BPAN patients, the autophagy flux was blocked (Saitsu 
et al., 2013), suggesting that WIPI4 depletion caused autophagy impairment is related to the 
BPAN pathology. However, it is unknown how WIPI4 regulates the autophagy pathway. The 
following work will try to understand the function of WIPI4 in the autophagy pathway and also 
investigate novel autophagy regulators came across within this process.
 
Chapter 2 Materials and Methods 
2.1 Cell culture 
2.1.1 Cell lines 
HeLa cells, C2C12 cells and HEK293 cells were cultured in basal media: Dulbecco’s Modified 
Eagles Medium (DMEM; Sigma D6546), supplemented with 10% Foetal Bovine Serum (FBS; 
Sigma F7524), 1% penicillin-streptomycin (Sigma P0781) and 1% L-glutamine (Sigma G7513). 
Stable cell lines (HeLa cell lines stably expressing mRFP-GFP-LC3 or GFP-Rab11 constructs 
were maintained with culture medium supplemented with 500 μg/mL G418 (Sigma). All lines 
were incubated at 37°C with 5% CO2. The HeLa GABARAP family-/- (referred to as HeLa 
GABARAP TRIPLE KO) cells were a gift from Prof M. Lazarou. Flp-In T-REx cell line integrated 
with GFP-p62 (Invitrogen, R780-07) is grown in the culture medium supplemented with 100 
μg/mL hygromycin B (Calbiochem, 400051) and 7.5 μg/mL blasticidin (Invitrogen, R210-01). 
The expression of p62 was turned on or off by adding or removing 1 μg/mL tetracycline (Sigma, 
T7660) to the cells for 24 hours. Cells are tested for mycoplasma contamination every other 
week. 
HeLa cell lines in which ATG16L1 was knocked out (referred to as HeLa ATG16L1 KO) were 
generated by Dr Maria Jimenez-Sanchez using double nickase Cas9. Each guide RNA results 
in cleavage of only one DNA strand, because only one of the two endonuclease sites of Cas9 
is active using nickase Cas9. Therefore, two guide RNAs are required for a double-strand 
break, increasing the accuracy of the cleavage. Guide RNAs were designed to target the first 
exon of ATG16L1 and cloned into pSpCas9n(BB)-2A-GFP (PX461: Addgene #48410). This 
construct was transfected into HeLa cells, and single-cell clones were grown following 
fluorescence-activated cell sorting (FACS). Complete knockout of ATG16L1 was confirmed 
using Western blotting. HeLa cells expressing the Cas9 backbone are selected by the same 
way and used as a control cell line, referred to as HeLa ATG16L1+ CTRL. 
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2.1.2 Splitting cells 
Cell lines were passaged when around 90%-100% confluent in T75 (75 cm2 area) flasks 
(Corning). When passaging, the media was aspirated first using a vacuum pump. Then cells 
were pre-washed with 3 mL phosphate buffered saline once to remove all the serum and then 
dissociated from the flask with 2 mL Trypsin-EDTA solution (Sigma) at 37°C for 5 minutes. The 
trypsin was then inactivated by mixing with 8 mL complete DMEM. Usually, the cell number 
was counted before seeding with countess slides (Invitrogen).  
2.1.3 Drugs and reagents 
Drugs and reagents used in this work are listed in Table 1. 





Bafilomycin A1 Lysosomal inhibitor Enzo Sciences 
(BML-CML-
0100) 
100-400 nM 4-18 h 4,5,6 
2-Iodoacetamide Deubiquitinase 
inhibitor 
Sigma (I1149) 10 mM n/a 5,6 
Cycloheximide Inhibitor of 
translation 
Sigma (C7698) 50 µg/mL 4-8 h 5,6 






Lysosensor Label neutral (blue) 










Sigma (C2211) 10 µM 6 h 5,6 
Mg2+ ATP In vitro 
ubiquitination assay 
Sigma (A2383) 2 mM n/a 6 























Sigma (P0044) 1% n/a 4,5,6 




in cell lysates from 






1 in 2 mL ddH2O 
to make 25 × 
stock solution 
n/a 4,5,6 
Proteinase K Cleavage of LC3-II 
to quantify the ratio 
of unsealed 
autophagosomes 
Sigma (P2308) 0.5% to 2% of 
the total protein  
5 min -30 
min 
4 
Table 2: Drugs and reagents used in this work. 
2.1.4 Transfection protocol 
For siRNA, the transfection was performed using Lipofectamine 2000 transfection reagent (Life 
Technologies #11668019). In accordance with the manufacturer’s protocol, 2.5 µl oligos were 
diluted in 100 μl opti-MEM (Gibco), 5 μl Lipofectamin 2000 in another 100 μl opti-MEM. Both 
the solutions were incubated at room temperature for 5 minutes. Then diluted Lipofectamine 
2000 was added into the oligo solution drop by drop, and the mixture was incubated for 20-30 
minutes. Opti-MEM was then added to the mixture (~208 μl) to make 1 mL solution. The 
solution was then added into one well of a 6-well plate and incubated in 37°C incubator for at 
least 4 hours, then changed to complete media. For two-round knockdown experiments, the 
transfection procedure was repeated on day 3 (48 hours later). After 72 hours or 96 hours, 
cells were harvested after treatment. Treatment of cells by Baf A1/ EBSS/ DMSO was carried 
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out 48 h after the final round of siRNA treatment. The cells were split in between if necessary. 
Cells were transfected at 70-80% confluency.  
For DNA, the transfection was performed using TransIT 2020 (Mirus Bio #MIR5400) with a 
procedure similar to above. Transfection reagent (5 μl) was used for each well of a 6-well plate.  
Target Type siRNA transfected per 




WIPI4 SMARTpool 100 or (60 + 50) 72 h or 96 h 4,5,6 
WIPI4 Individual siRNAs 60 + 50 96 h 4,5 
ATE1 SMARTpool 50 72 h 6 
ATG2A SMARTpool 100 + 50 96 h 4 
ATG2B SMARTpool 100 + 50 96 h 4 
GABARAP SMARTpool 
100 (or 37.5 when three 
family members are 
knocked down together) 
72 h 5 
GABARAPL1 SMARTpool 72 h 5 
GABARAPL2 
(GATE16) 
SMARTpool 72 h 5 
MIB1 SMARTpool 100 72 h 5 
UBR4 SMARTpool 50 72 h 5,6 
UBR5 SMARTpool 25 72 h 5,6 
UBR5 Individual siRNAs 25 72 h 6 
 Table 3: siRNAs used in this work. 
2.1.5 SiRNAs 
siRNAs were ordered from Dharmacon (GE Healthcare). Details of siRNAs used in this work 
can be found in Table 2. siRNA in tubes was centrifuged at 5000 rpm for 5 minutes to bring 
the all the powder to the bottom of the tube, then dissolved in 1 × RNAase free buffer 
(Dharmacon) to make a 20 µM stock.  The starting working concentration is 50 nM. In further 
experiments, the working concentration of siRNA was adjusted according to the knockdown 
efficiency and cell status after transfection.   
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2.1.6 Constructs 
pMRXIP-GFP-hATG2A was a kind gift from Mizushima Lab (Velikkakath et al., 2012). RFP-
LC3 was a kind gift from Yoshimori Lab (Kabeya et al., 2000), which is a rat protein.  pEGFP–
HTT exon-1-Q74 is a lab reagent. GFP-WIPI4, HA-ubiquitin, GFP-UBR5, GFP-UBR5-C2768A, 
Tag2B-UBR5 and Tag2B-UBR5-C2768A are from Addgene. pEGFP-C1 is from Clontech. 
pFLAG-CMV-5a is from Sigma. 
nGFP-GABARAP, nGFP-GABARAPL1 and nGFP-GABARAPL2 were generated by cloning 
the coding sequence of relevant genes ordered from GeneScript onto the pEGFP-C1 
backbone.The restriction sites used are: HindIII and BamHI (for GABARAP); EcoRI and BamH-
I (GABARAPL1); EcoRI and KpnI (GABARAPL2). The plasmids were propagated in E.coli. 
High-efficiency DH5α competent cells (Bioline US Inc) were used for transformation according 
to the manufacturer’s protocol. Plasmid isolation was performed using a Maxi prep isolation kit 
(Life technologies #K210017). The concentration was measured with a spectrophotometer 
(Nanodrop1000, Thermo Scientific) and TE buffer as a blank. 
2.1.6.1 Site-directed mutagenesis 
Point mutations were introduced into nGFP-GABARAP constructs using the Q5 Site-Directed 
Mutagenesis  kit (NEB E0554S) according to the manufacturer’s instructions. Primer 
sequences are found in Table 3. GABARAP mutant constructs were sequenced with universal 
primers. Flag-UBR5 was generated by Addgene by deleting the c-termini His tag from the 
Tag2B-UBR5 construct. UBR5 constructs were sequenced with both CMV-F and UBR5-2637-
F (CACAGAATGTTGGTAGTTG) depending on the region of interest.  
DNA construct Mutation Primer sequence 
nGFP-K2P-Forward K2P CAAGCTTATGccGTTCGTGTACAAAGAAG 
nGFP-K2P-Reverse GCTCGAGATCTGAGTCCG 
nGFP-G116A-Forward G116A AGTGTCTACGcTCTGTGAGGATC 
nGFP-G116A-Reverse TTCGTCACTGTAGGCAATG 
Table 3: Primers used in site-directed mutagenesis. 
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2.2 Western blotting 
2.2.1 Harvesting cells 
Cells were harvested by Lysis buffer or Laemmli buffer. 
When protein quantitation using Bradford’s method is essential, for example, when samples 
vary in confluence or the lysates would be used for detecting aggregation clearance, lysis 
Buffer is necessary. Protein concentrations were assayed using the BioRAD DCTM Protein 
Assay kit (a modified Lowry protein assay; BioRAD 5000112) and quantified at 750 nm using 
a plate reader. Protein concentrations were then adjusted for each sample. Samples were 
loaded onto gels and the remainder frozen at -20°C. 
Lysis Buffer B recipe:  
10 mM Tris pH6.8, 68.5 nM NaCl, 0.5 mM EGTA, 1% Triton X100, 5% glycerol, protease 
inhibitor (Roche) and phosphatase inhibitors (cocktails 2 and 3 from Sigma).  
If samples are of similar confluence, Laemmli buffer is advantageous because it shortens the 
process and reduces errors and variance. 
2 × Laemmli Buffer recipe: 
62.5mM Tris pH 6.8, 2% w/v SDS, 10% glycerol, 50 mM DTT, 0.01% w/v bromophenol blue. 
Cells were scraped with a scraper and lysates were mixed well before transferring into cold 
Eppendorf tubes. Samples were boiled for 5 minutes at 100°C. 




Actin rabbit polyclonal Sigma (A2066) WB 3,4,5 
ATE1 mouse monoclonal Santa Cruz (Sc271220) WB 5 
ATG2A rabbit polyclonal Cell signalling (15011S) WB/ IF 3,4 
ATG16L1 rabbit monoclonal 
(D6D5) 
Cell Signalling (8089) IF 3 
CD63 mouse monoclonal Abcam (ab8219) IF 3 
CATHEPSIN D mouse monoclonal BD Biosciences (610801) WB 5 
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GABARAP rabbit polyclonal Abgent (AP1821A) WB/IF 4,5 
GABARAPL1 rabbit polyclonal Abcam (ab86467) WB/IF 4,5 
GABARAPL2 
(GATE16) 
rabbit polyclonal MBL (PM038) WB/IF 4,5 
GAPDH mouse monoclonal, 
6C5 
Abcam (ab8245) WB 5 
GFP rabbit polyclonal Clontech (632592) WB, IP 3 
GM130 mouse monoclonal 
(clone 35) 
BD Biosciences (610822) IF 5 
K48-linked 
ubiquitin 
rabbit polyclonal Cell signalling (8081) WB 4,5 
K63-linked 
ubiquitin 
rabbit polyclonal Cell signalling (5621) WB 4,5 
LC3B rabbit polyclonal Novus Biologicals (NB100-
2220) 
WB 3,4 
LC3B rabbit polyclonal Abcam (ab192890) WB/IF 3,4,5 
MIB1 rabbit polyclonal Sigma (M5948) WB 4,5 
P62 mouse monoclonal BD Biosciences Transduction 
Lab (610833) 
WB 5 
p62 rabbit polyclonal MBL (PM045) WB 5 
PCM1 mouse monoclonal BD Biosciences (610822) IF 4 
Γ-tubulin mouse monoclonal Sigma (GTU-88/ T6557) IF 4 
TGN46 rabbit polyclonal A kind gift from Dr Matthew 
Seaman 
IF 6 
Tubulin (α) mouse monoclonal 
(DM1A) 
Sigma (T9026) WB 5 
WIPI4 rabbit polyclonal Proteintech (19194-1-AP) WB/IF 3,4,5 
WIPI4 (229-240) mouse Monoclonal  Sigma (SAB1101582) IF 3,4,5 
Ubiquitin mouse monoclonal MBL (D058-3) WB 4 
UBR4 rabbit polyclonal Abcam (ab86738) WB 4,5 
46 Materials and Methods 
 
UBR5 rabbit polyclonal Bethyl laboratory (A300-
573A) 
WB 4,5 
Table 4: Primary antibodies used in this work 
 
Table 5: Secondary antibodies used for this work. 
2.2.2 Western blotting protocol 
Polyacrylamide gels were prepared freshly with the percentage dependent on the size of the 
proteins of interest. Gels were run using Tris-glycine running buffer (25 mM Tris, 192 mM 
glycine, 0.05% SDS). Equal volumes of the sample were loaded in each lane and any empty 
lanes loaded with 1X sample buffer. Either SeeBlue Plus2 Prestained Protein Standard 
(ThermoFisher LC5925) or PageRuler Plus Prestained Protein Ladder (ThermoFisher 26619) 
were used as molecular weight markers.  
Secondary antibodies 
Target Conjugation Host Company Application 
Rabbit IgG IR dye 680 goat Licor (926-32221) WB 
Rabbit IgG IR dye 800 goat Licor (926-32211) WB 
Rat IgG IR dye 800 goat Licor (926-32219) WB 
Mouse IgG IR dye 680 goat Licor (926-68070) WB 
Mouse IgG IR dye 800 goat Licor (926-32210) WB 
Mouse IgG HRP sheep GE Healthcare (NA931V) WB 
Rabbit IgG HRP donkey GE Healthcare (NA934V) WB 
Goat IgG HRP rabbit Thermo Fisher Scientific (611620) WB 
Rabbit IgG Alexa 488 goat Thermo Fisher Scientific (A11008) IF 
Rabbit IgG Alexa 647 goat Thermo Fisher Scientific (A21428) IF 
Rabbit IgG Alexa 555 goat Thermo Fisher Scientific (A21245) IF 
Mouse IgG Alexa 488 goat Thermo Fisher Scientific (A11001) IF 
Mouse IgG Alexa 647 goat Thermo Fisher Scientific (A21236) IF 
Mouse IgG Alexa 555 goat Thermo Fisher Scientific (A21422) IF 
2.3 Confocal Microscopy 47 
 
Gels were transferred using the wet transfer method on to PVDF membrane (Immobilon-FL for 
LiCor detection, Immobilon-P for ECL detection; Merck-Millipore IPFL00010 and IPVH00010 
respectively). The transfer buffer was Tris-glycine (25 mM Tris, 192 mM glycine). Activation of 
the PVDF membrane is performed by soaking it in pure methanol for 5-10 s. For small proteins, 
20% methanol transfer buffer is recommended. Since methanol interferes with SDS-binding of 
large molecular weight (MW) proteins, and the protein will precipitate if transferred in a high 
concentration of methanol, 10% or no methanol transfer buffer was used for large MW protein, 
including UBR4 and UBR5. On completion of transfer, the membrane was blocked in 5% Mavel 
milk or 3% BSA with PBST (0.5% Tween 20) for 1 hour, shaking in room temperature. 
Membranes were then stained with primary and secondary antibodies diluted in block buffer 
with washes between and after.  
For antibodies that gave strong signals, fluorophore-conjugated secondary antibodies were 
used, and membranes were imaged directly using LI-COR, Odyssey. For WIPI4, GABARAP-
II, GABARAPL1-II, GATE16-II, UBR5, UBR4, MIB1 and ATG2A, horseradish peroxidase-
linked (HRP) secondary antibody in conjunction with electrochemiluminescent detection 
reagents (GE Healthcare) and X-ray film are required to detect the signal.  
2.2.3 Antibodies 
Primary antibodies used are detailed in Table 4, and secondary antibodies in Table 5. 
2.3 Confocal Microscopy 
For fixed imaging, cells were cultured on coverslips, fixed with 2% paraformaldehyde in culture 
medium for 12-15 minutes at room temperature, or by incubation in ice-cold methanol for 5 
minutes at -20°C for endogenous LC3 staining. Cells fixed with paraformaldehyde are then 
washed twice with PBS, followed by permeabilization with 0.2% Triton X100 in PBS for 5 
minutes. Cells were blocked with 1% BSA in PBS for 30 min and incubated with primary 
antibodies for 1-2 hours. After two quick washes with PBS and once with 1% BSA, samples 
were incubated with secondary antibodies for 1 hour and washed with PBS for three times. 
Samples were mounted with Prolong Gold anti-fade reagent (#P36935) with DAPI and 
observed using Zeiss instruments (LSM710, LSM780 and LSM880). Ten to fifteen images with 
a mean of 4 cells per image were taken per condition per experiment. Exposure settings were 
unchanged throughout acquisition. Images were processed with Zen. 
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For live-cell imaging, cells were seeded into 3 cm MatTek glass-bottomed culture dishes 
(MatTek Corporation P35G-1.0-14-C). The starting confluence was 0.3×106 per plate. When 
the confluency reached 1×106, Herpes buffer was added to a final concentration of 20 mM to 
maintain the pH in media. During imaging, cells were put in a 5% CO2, 37°C incubator. Imaging 
was performed within 3 hours.  
2.4 GFP-Htt-Q74 aggregates assay 
GFP-Htt-Q74 constructs (1.5 µg) were transfected 24 hours after the final round of siRNA 
knockdown. Two hundred GFP-Htt-Q74 transfected cells were selected and the number of 
cells with aggregates were counted using fluorescence microscopy. Slides were counted blind. 
The experiments were performed in triplicates and repeated at least twice. 
2.5 Cathepsin L activity assay 
Cathepsin L activity measurement was performed with the Cathepsin L Activity Assay Kit 
(Fluorometric) (Abcam ab65306) according to the manual. Cathepsin L activity is determined 
by the release of a fluorescent moiety generated by the cleavage of a synthetic substrate by 
Cathepsin L. Cell samples were harvested and centrifuged (5 minutes, 13000 x g, 4°C) to 
remove cell debris. CL buffer was added to samples along with 200 µM Ac-FR-AFC substrate 
and incubated at 37°C for 2 hours before fluorescence was determined. 
2.6 Protease protection 
HeLa cells were suspended in homogenization buffer (10 mM HEPES-KOH, pH 7.4, 0.22 M 
mannitol, 0.07 M sucrose, protease inhibitors and phosphatase inhibitors of the recommended 
concentrations in their manuals). The homogenization was done with 10 strokes using a 
syringe with a 27-gauge needle. The postnuclear supernatant was recovered by centrifugation 
at 300 × g for 5 minutes. The lysate was centrifuged at 100,000 × g for 30 minutes. The pellets 
were resuspended in the 30 mM Tris-Cl pH 7.4 buffer after 2 washes. To analyze detergent 
solubility, each sample was incubated with 1% Triton X-100 on ice for 30 min and then 
centrifuged at 100,000 × g for 30 minutes. To examine proteinase K sensitivity, each fraction 
was treated with the same amount of proteinase K (the raitio of proteinase K vs total protein is 
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1 to 100) on ice for 20 minutes. The samples were then denatured in 4 times SDS–PAGE 
sample buffer, immediately boiled, and analyzed by SDS–PAGE. 10 µg of total proteins were 
loaded for each sample.  
2.7 Immunoprecipitation 
GFP-tagged proteins (GFP-WIPI4, GFP-GABARAP and GFP) were pulled down using GFP-
TRAP beads (ChromoTek, #gtma-100) according to the manufacturer’s protocol, but with Lysis 
buffer B. Cells were washed with ice-cold PBS and incubated on ice for 30 minutes in Lysis 
buffer B. Cells were then scraped, and the lysate centrifuged at 13000 x g for 15 minutes at 
4°C and the post-nuclear supernatant kept. A protein assay was carried out, and tubes set up 
for each IP sample with equal amounts of protein in each and the volume adjusted to 0.5 mL 
with IP lysis buffer. Samples were incubated with 20 µl washed GFP-Trap Dynabeads per tube 
for 1 hour, at 4°C on a rotating wheel. GFP-Trap Dynabeads were washed using Lysis buffer 
B for three times before being resuspended in 30 µl 2x Laemmli buffer and boiled for 5 minutes 
to detach the protein from the beads. Samples were analysed by Western blotting. Proteins 
were resolved by SDS-PAGE.  
2.8 Isolation of recombinant UBR5 and UBR5-C2768A Proteins  
N-terminal Flag-tagged UBR5 WT and UBR5 catalytic dead mutants were purified from 
HEK293 cells transfected with Flag-UBR5 WT, Flag-UBR5-His, Flag-UBR5-C2768A-His 
plasmids 24 hours before lysis. Cells were lysed in Flag lysis buffer (20 mM Tris-HCl, pH 6.8, 
137 mM NaCl, 1 mM EGTA, 1% Triton x100, 1mM DTT, 10% Glycerol, protease inhibitors 
cocktail, phosphatase inhibitor cocktail 2 & 3) for 15 minutes on ice and cell lysates were 
centrifuged at 13000 x g for 15 minutes at 4°C and the post-nuclear supernatant kept. Cell 
lysates were incubated with anti-FLAG-affinity beads (Sigma, #A2220) in FLAG lysis buffer in 
gravity columns. The beads were then washed with a series of buffers: 
Wash 1: 10 mM Tris pH 7.4, 650 mM NaCl, 1 mM EDTA, 1% Triton X100, 0.5% BSA 
Wash 2: 10 mM Tris pH 7.4, 650 mM NaCl, 1 mM EDTA, 1% Triton X100 
Wash 3: 10 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X100 
Washes 4 and 5: 10 mM Tris pH 7.4, 650 mM NaCl, 1 mM EDTA 
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After washing, the proteins were eluted with 3X FLAG Peptides (#F4799, Sigma) in 10 mM 
Tris pH 7.4 and used for in vitro ubiquitination assays directly or after short storage at 4°C. 
2.9 In vitro ubiquitination assay 
There are two well-acknowledged in vitro ubiquitination reaction approaches. The first is to use 
separately purified recombinant substrate and E3 ligase proteins, supplemented with other 
conjugation reaction ingredients including ATP-Mg2+, recombinant ubiquitin, E1 and E2. The 
other method is to pull down the substrate protein together with the E3 ligase protein from 
cultured cells, adding supplements as listed above. Both approaches were examined, but the 
first gave stronger GABARAP signals with more reproducible results. The Ubiquitin 
Conjugation Initiation Kit (Boston Biochem, #K-995) is used for both assays with the 
manufacturer’s protocol.  
To resemble a 20 μl reaction, the following ingredients are combined in 0.5 or 1.5 mL 
polypropylene tubes: E3 Ligase Reaction Buffer (10X), approximately 100 µM ubiquitin, 5-10 
µM His-GABARAP (in my application, 0.5-0.8 μg), 0.5 µl E2 UBCH4 (1 µM), 1 µl E1 UBA1 (100 
nM), no less than 1 µM E3 ligase. If the total volume is still less than 18 µl, ddH2O may be 
added. 
The conjugation reaction is initiated by adding 10 mM Mg2+-ATP. After 30-60 minutes in a 37°C 
water bath, 0.5 µL EDTA (20 mM) or 1 µL DTT (100 mM) is added to terminate the reaction. 
The samples were then resolved by SDS-PAGE gel.  
2.10 Labelling of nascent proteins by Click Chemistry  
Metabolic labelling was performed using the Click-iT Metabolic Labelling kit (Life Technologies, 
Grand Island, NY, USA) according to the manufacturer’s protocol. Cells were washed with PBS 
(pre-warmed) and cultured in conditioned medium (methionine-free, but all other ingredients 
of culture medium) for 1 hour to deplete the intracellular methionine reservoir. After that, 
nascent proteins begin to incorporate AHA (L-azidohomoalanine, a methionine surrogate) 
during a 1 hour incubation in the conditioned medium supplemented with 50 μM AHA. After 
labelling, the cells were lysed, and AHA-labelled proteins were conjugated to biotin. The 
biotinylated proteins were purified by streptavidin magnetic beads after a 2-hour incubation at 
2.11 Mass spectrometry analysis for WIPI4 interactors and for the poly-
ubiquitination sites on GABARAP 
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room temperature and multiple washes with 0.001% Triton PBS. AHA labelled proteins were 
then eluted with 2x laemmli buffer and analysed by SDS-PAGE.  
2.11 Mass spectrometry analysis for WIPI4 interactors and for the 
poly-ubiquitination sites on GABARAP 
For WIPI4 interactors, WIPI4-GFP was immunoprecipitated using GFP-Trap beads using the 
protocol previously described. Samples were resolved into a pre-cast 4-12% Bis-Tris 
polyacrylamide gel (Novex, Thermo Fisher Scientific). The lanes were excised and cut in 3 
approximately equal pieces and the proteins reduced, alkylated and digested in-gel. The 
resulting tryptic peptides analysed by LC-MSMS using a Q Exactive coupled to an 
RSLCnano3000 (Thermo Scientific). Raw files were converted to mzML using MSConvert 
(Proteowizard) and searched against a human Uniprot database (downloaded 090614, 20,264 
entries) using MASCOT 2.3. 
For identification of the putative sites of ubiquitination on GABARAP, HeLa cells transfected 
with GABARAP-G116A-cGFP and HA-Ub, or GABARAP-K2P-G116A-cGFP and HA-Ub for 24 
hours, treated in the last 6 hours with a proteasome inhibitor (MG132 10 µM). Cells were lysed 
in Lysis buffer B supplemented with deubiquitinase inhibitors (25 mM N-Ethylmaleimide and 
10 mM 2-Iodoacetamide) and GABARAP-cGFP mutant proteins were immunoprecipitated. 
The samples were eluted with 2x laemmli buffer. The elutions were resolved and processed 
with procedures outlined above and analysed by LC-MSMS. Raw files were processed in 
Maxquant and PEAKs. GlyGly (K) was set as a variable modification and carbamidomethyl (C) 
as a fixed modification. Peptides were filtered to high confidence (0.01 FDR) using Percolator. 
2.12 Sequence Alignment  
Clustal Omega1 was used for multiple sequence alignment. The total or partial conservation 
between sequences are highlighted. 
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2.13 Statistics 
Western blots were quantified with Image Studio Lite Ver5.2 software. Fiji-ImageJ was used 
to quantify membranes stained with HRP-conjugated secondary antibodies. Statistical analysis 
and the graphs were done with Excel and Prism 7.  
Volocity software and Fiji-Image J were used for the analysis and processing of confocal 
images. For colocalization analysis of confocal images, Mander’s Coefficient was used. A 
minimum of 40 cells were examined in each condition. 
For simple comparisons, two-tailed Student’s T-tests were used, unless there was a legitimate 
reason to expect the change to be in a particular direction, in which case a one-tailed test was 
used. ∗= p ≤ 0.05; ∗∗= p ≤0.01; ∗∗∗= p≤0.001. A P value of 0.05 was taken as the borderline for 
statistical significance. Most experiments were repeated at least three times. For experiments 
using different conditions, the data from single representative experiments were reported to 
minimise effects of heterogeneity between experiments. 
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Chapter 3 WIPI4 regulates a late stage of 
autophagosome formation in basal autophagy 
3.1 WIPI4 is required for the degradation of LC3-II 
3.1.1 WIPI4 KD increases LC3-II in basal conditions but not in the presence of 
BafA1 
To test whether WIPI4 is involved in autophagy, WIPI4 was knocked down in HeLa cells using 
small interfering RNA (siRNA), and LC3-II levels were measured. During autophagy, cytosolic 
LC3 is cleaved by ATG4 to form LC3-I, which is then conjugated to phosphatidylethanolamine 
to form LC3-II, which decorates autophagosome membranes (Kabeya et al., 2000). Therefore, 
LC3-II levels positively correlate with the number and volume of autophagosomes in the cells. 
This increase in LC3-II might be due to either increased autophagosome formation or impaired 
autophagosome flux. In order to differentiate between these situations, autophagosome 
degradation was blocked using a saturating concentration of Bafilomycin-A1 (Baf), a potent 
inhibitor of the lysosomal V-ATPase which impairs both autophagosome degradation and 
autophagosome-lysosome fusion. Thus, if there is an induction of autophagosome formation, 
LC3-II levels would increase in treated cells compared to the control following Baf treatment. 
After transfection with SMARTpool (sp) WIPI4 siRNA, the LC3-II levels increased compared 
to control cells transfected with control (scramble (scr) siRNA (Fig.3.1A). However, the LC3-II 
levels with Baf were not significantly different between control and SMARTpool knockdown, 
indicating that LC3-II degradation was impaired under WIPI4 depletion (Fig.3.1A). The 
knockdown efficiency is shown in the right panel of Fig.3.1A. WIPI4 depletion by sp siRNA also 
increased LC3-II levels in starvation conditions (Fig.3.1B). 
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In order to exclude off-target effects, the knockdown experiments were repeated with 
independent deconvoluted oligos. All the oligos increased LC3-II levels in control conditions 
(Fig.1.2A) but did not change LC3-II levels under BafA1 treatment (Fig.3.2A). To validate the 
autophagy phenotype seen under WIPI4 depletion, rescue experiments were performed by 
overexpressing WIPI4-GFP in cells treated using WIPI4 oligo 10 siRNA. This treatment 
reduced LC3-II levels to the same as control cells transfected with empty-GFP, indicating that 
the increase of LC3-II levels in basal conditions was specifically caused by WIPI4 depletion 
(Fig.3.2B). 
Consistent with the LC3 blots, both the size and number of endogenous LC3 vesicles 
increased (Fig.3.3 A&B) with WIPI4 knockdown. ATG16L1 labels autophagosome precursors 
that evolve into LC3 positive autophagosomes (Pavel et al., 2016). WIPI4 knockdown 
increased both the size and number of ATG16L1 positive vesicles (Fig.3.3 C&D). Moreover, 
the colocalization of ATG16L1 and LC3 increased in WIPI4 depleted cells, implying that the 
autophagy flux was blocked after the autophagosome recruitment of ATG16L1 and LC3 
(Fig.3.4 A&B). Fig.3.4C shows the knockdown efficiency of WIPI4 siRNA in the experiment in 
Fig.3.3 and Fig.3.4. 
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3.1.2 Knockdown of WIPI4 blocked phagophore-autolysosome transition  
In order to confirm which stage of the autophagic pathway was impaired, HeLa cells stably 
expressing tandem fluorescent-tagged LC3 (Sarkar et al., 2009) were used to quantify 
autophagosomes (including precursors) and autolysosomes with and without WIPI4 
knockdown. Tandem fluorescent-tagged LC3 (mRFP-GFP-LC3) is an assay which can be 
used to monitor autophagic flux. In newly formed autophagosomes at physiological pH, both 
mRFP and GFP are stable, whereas the autolysosomes have only mRFP signal due to 
quenching of the GFP in the acidic lysosomal environment (Kimura et al., 2007). 
HeLa cells stably expressing mRFP-GFP-LC3 were transfected with deconvoluted WIPI4 
siRNA Oligos 10 and 12 and analysed by live cell imaging. Interestingly, knockdown of WIPI4 
with both oligos led to an increase in the number of GFP vesicles but a decrease of RFP-only 
vesicles in full media (Fig.3.5 A&B). BafA1 treatment was used as a positive control to verify 
the reliability of this experiment. As shown in Fig.3.5B, the number of GFP vesicles greatly 
increased in BafA1 treated cells (Fig.3.5B). Fig.3.5C shows the knockdown efficiency of WIPI4 
by both oligos. This observation indicated that WIPI4 knockdown increases LC3-II levels by 
reducing its degradation.  
  




3.1 WIPI4 is required for the degradation of LC3-II 61 
 
3.1.3 WIPI4 knockdown impairs the removal of autophagy substrates 
If WIPI4 depletion blocks autophagic flux, it should also slow down the clearance of autophagy 
substrates. Therefore, aggregate-prone proteins (GFP-Htt-Q74 and GFP-p62) were used to 
monitor clearance. As an autophagy substrate, the proportion of cells with GFP-Htt-Q74 
aggregates increases linearly with its expression levels (Narain et al., 1999) and correlates 
inversely with autophagy activity (Ravikumar et al., 2002). Consequently, the clearance 
efficiency of GFP-Htt-Q74 can be measured by the percentage of cells with aggregates. The 
proportion of cells with GFP-Htt-Q74 aggregates increased in WIPI4 knockdown cells 
compared to control cells (Fig.3.6A).  
p62/SQSTM1 (hereafter p62) is an autophagy cargo protein which physically links autophagy 
substrates to LC3/GABARAP family members located on the autophagosome membranes. 
p62 localised at the inner surface of phagophores will be encapsulated in autophagosomes 
and be degraded together with other luminal contents (Korolchuk et al., 2010). Thus, p62 can 
also be classified as an autophagy substrate, and its levels inversely correlate to the autophagy 
activity. GFP-p62 Flp-In T-REx cell line is an inducible autophagy flux reporter system (Larsen 
et al., 2010). The expression of p62 can be turned on or off by adding or removing the inducer 
(tetracycline). Following expression, the inducer is removed, and the autophagic flux can be 
determined as the rate of decay of GFP-p62. GFP-p62 clearance was significantly retarded 24 
hours after turning-off the induced expression in WIPI4 siRNA treated cells compared to control 
(Fig.3.6C). The knockdown efficiency of WIPI4 is shown in Fig.3.6 B&D. Altogether, WIPI4 
depletion compromised the clearance of autophagy substrates, indicating that WIPI4 is a 
positive regulator of autophagy function.   
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3.1.4 WIPI4 knockdown slows down the degradation of nascent LC3-II proteins  
To clarify whether LC3-II accumulation was caused by the increase in its formation or a defect 
of its degradation, Click-iT assay was performed to measure the formation and degradation 
rate of LC3-II. Cells treated with control and WIPI4 siRNA were incubated with conditioned 
media, and newly synthesized protein was labelled during the incubation with L-
azidohomoalanine (AHA). The labelled protein, including LC3-II, was biotinylated and purified 
by streptavidin beads. The levels of AHA-LC3-II synthesized during one hour were not 
significantly changed by WIPI4 depletion (Fig.3.7 A&C). However, after three hours, the AHA-
LC3-II levels began to decrease much slower in WIPI4-depleted cells compared to control cells 
(Fig.3.7 A&D). The AHA-LC3-II levels increased for the first three hours following incubation 
with AHA. This is likely to be due to a pool of AHA in the cells which has not been exhausted 
and protein synthesis continuing. 
In summary, the depletion of WIPI4 downregulates autophagy functions. The LC3-II western 
blots demonstrate that autophagosomes accumulate in WIPI4 depleted cells. Htt-Q74-GFP 
aggregation assay and GFP-p62 clearance experiment show that WIPI4 is a positive regulator 
of autophagy. The experiment with the mRFP-GFP-LC3 stable cell line and Click-iT assay 
confirmed that the loss of WIPI4 function accumulates LC3-II by impairing its degradation. 
Defects in any of the three following processes can cause the impaired degradation of LC3:  
i. LC3-II degradation in lysosomes, or lysosome degradative function 
ii. The trafficking of LC3 positive autophagosomes to lysosomes, namely autophagosome-
lysosome fusion 
iii. Autophagosome formation delay between LC3 conjugation and autophagosome closure 
The three processes above were assessed separately to understand which of them is /are 
responsible for the WIPI4 knockdown phenotype. 
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3.2 WIPI4 knockdown impairs a late stage of autophagosome 
formation  
3.2.1 Lysosome activity was not impaired by WIPI4 knockdown 
If WIPI4 knockdown blocks autophagy through disrupting lysosomal structures, the activity of 
the lysosomes may be reduced. The lysosome activity was monitored by three markers: 
Cathepsin L activity, Cathepsin D maturation by western blot, and pH.  
First, the activity of Cathepsin L as a marker of lysosome function was measured. Cathepsins 
are soluble lysosomal aspartic endopeptidases. Less active Cathepsins indicate the decrease 
of the degradative capability of lysosomes. Conversely, the Cathepsin L activity increased in 
basal media by WIPI4 knockdown (Fig.3.8).  
Second, a decrease of mature Cathepsin D and increase of procathepsin D and intermediates 
indicate decreased lysosome function and defective endo-lysosome trafficking (Benes et al., 
2009). On the contrary, Cathepsin D maturation was not decreased by WIPI4 knockdown 
(Fig.3.9). Instead, the procathepsin D and intermediate levels increased similarly with mature 
Cathepsin D.  
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Third, since an acidified environment is required for the activation of digestive enzymes in the 
lysosomes, acidification of lysosomes with and without WIPI4 siRNA treatment was measured 
with LysoSensor. Consistently, WIPI4 depletion slightly increased the ratio of acidified 
lysosomes versus neutral lysosomes in both basal and starved conditions (Fig.3.10). BafA1 
treatment decreased the ratio of acidified to neutral lysosomes and was used as a negative 
control. The mechanism of WIPI4 upregulating lysosome function is beyond the scope of this 
chapter.  Cells of Fig.3.9& 3.10 are from the same siRNA transfection experiment and the 
knockdown efficiency of WIPI4 proteins shown in Fig.3.9.  
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Taken together, WIPI4 depletion does not decrease the levels of functional lysosome 
enzymes. 
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3.2.2 WIPI4 knockdown does not block autophagosome-lysosome fusion 
The above observations indicated that WIPI4 regulates autophagy by promoting 
autophagosome-maturation or the trafficking of autophagosome to lysosomes (fusion). First, 
to understand whether there is a defect in fusion, the colocalization of LC3 and lysosome 
markers were analysed. If WIPI4 knockdown impairs the traffic of autophagosomes to the 
lysosomes, the colocalization of LC3 (autophagosome marker) and LAMP1/CD63 
(lysosome/late endosome markers) should be decreased. The increased size/number or 
clustering of lysosomes may artefactually increase the colocalization. Nocodazole is a 
microtubule-depolymerizing drug, which dissociates lysosomes from the non-fused 
autophagosomes in their close proximity (Kuhn et al., 2006).  
As shown in Fig.3.11, WIPI4 knockdown increased the colocalization of endogenous LC3 and 
CD63 under basal conditions. However, there was no significant increase when cells were 
exposed to Nocodazole (Fig.3.12).  Therefore, the traffic of autophagosomes to lysosomes 
was not affected. The knockdown efficiency of WIPI4 proteins of Fig.3.10 & 3.11 is shown in 
Fig.3.10 because the cells are from the same siRNA transfection experiment.   
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3.2.3 WIPI4 regulates a late stage of autophagosomes formation, which is later 
than ATG2 regulated expansion but no later than the closure  
The final stage to investigate is after LC3-II conjugation and no later than autophagosome 
closure.  Proteinase K cleaves LC3-II from exposed autophagosome membranes (Velikkakath 
et al., 2012). Therefore, sealed autophagosomes would have a lower ratio of cleavable versus 
uncleavable LC3-II proteins compared to unsealed autophagosomes. As shown in Fig.3.13, 
ATG2A/B knockdown resulted in less LC3-II after proteinase K treatment, suggesting an 
increased ratio of cleavable and uncleavable LC3-II, which means either a bigger proportion 
of unsealed autophagosomes or smaller autophagosomes. In comparison, WIPI4 knockdown 
only slightly sensitised LC3-II levels to proteinase K treatment in basal conditions.  
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This observation suggests that WIPI4 and ATG2A/B regulate the ratio of cleavable LC3-II 
versus uncleavable LC3-II differently, which reminded me of the fact that ATG2 loss of function 
reduces the size of autophagosomes (Tang et al., 2019) while WIPI4 loss of function increases 
the size of autophagosomes (Fig.3.3). Altogether, the above information indicates that WIPI4 
functions in expansion but later than ATG2, and WIPI4 also functions no later than closure 
because the autophagosome size is still adjustable/ autophagosomes are not yet completed 
when WIPI4 functions. The specificity of ATG2A and ATG2B siRNAs has been verified 
previously in the lab and data is not shown here.  
 
Next, it was examined whether there was a defect after LC3-II conjugation and before the 
closure. Rab11 tubules form a platform for autophagosome formation (Puri et al., 2018). LC3-
II positive membrane buds off from Rab11 positive recycling endosomes to form 
autophagosomes. If WIPI4 is required for the scission of LC3-II positive structures from 
recycling endosomes, the colocalization of Rab11 and LC3 should increase when WIPI4 is 
depleted. However, Fig.3.14 shows that the colocalization of Rab11-GFP and LC3 was not 
changed in both basal and starved conditions. Based on the above results, WIPI4 regulates 
the closure of autophagosomes, which may happen after the scission of LC3-II structures from 
recycling endosomes.  
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3.3 WIPI4 interacts with ATG2 but is not required for the 
recruitment of ATG2 onto autophagosomes 
WIPI4 and ATG2 may function in the same stage of the autophagy pathway (Lu et al., 2011). 
Also, Mizushima et al., 2012 claimed that ATG2 has a function in autophagosome closure. 
Therefore, it was hypothesized that WIPI4 and ATG2 might interact with each other and 
cooperate to regulate autophagosome closure in HeLa cells.  
3.3.1 WIPI4 colocalizes and interacts with ATG2 
To examine whether and how WIPI4 and ATG2 function together, the interaction and 
colocalization of WIPI4 with ATG2 in HeLa cells was examined. Endogenous WIPI4 locates 
both in the cytosol and on puncta in fed conditions (Fig.3.15A). More WIPI4 is recruited onto 
vesicles after 1-2 hours starvation (Fig.3.15A ), whereas WIPI4-GFP is mostly cytosolic in fed 
conditions. WIPI4-GFP vesicles dramatically increase after 1-2 hours of starvation (Fig.3.15B). 
To obtain a quantifiable number of ATG2 and WIPI4 vesicles, the immunofluorescence was 
performed in starvation conditions. ATG2 and WIPI4 colocalised after starvation, 30% of WIPI4 
vesicles were positive for ATG2 (Fig.3.15B), and 23% of ATG2 vesicles were WIPI4-positive 
(Fig.3.15B). The absolute number of WIPI4-GFP vesicles in starvation was approximately 85 
per cell, comparable with the number of autophagosomes (Fig.3.15C). Moreover, it was 
confirmed that WIPI4 interacts with ATG2 in HeLa cells (Chapter 4, Fig.4.6). These data 
indicate that WIPI4 and ATG2 function together or serially.  
3.3.2 WIPI4 loss of function was rescued by ATG2-GFP in basal conditions 
To further confirm whether WIPI4 and ATG2-GFP function in the same process, ATG2-GFP 
rescue experiment was performed by quantifying LC3 dots immunofluorescence.  
In conjunction with western blots, with the same treatments were examined.  Fig3.16A shows 
that the number and area of LC3-II vesicles were increased by WIPI4 knockdown, and the 
increase was rescued by WIPI4-GFP overexpression (Fig.3.16B). LC3 vesicles in WIPI4 
depleted cells transfected with GFP constructs were bigger compared to that rescued by 
WIPI4-GFP as shown in Fig.3.16C.   As shown in Fig.3.16D, the WIPI4 siRNA transfected cell 
with ATG2-GFP vesicles (labelled by the white rectangle) contains much less LC3 vesicles 
than the one without ATG2-GFP (labelled by the blue rectangle) vesicles.  The LC3 vesicles 




in WIPI4 knockdown cells expressing ATG2-GFP were also less than in the WIPI4 siRNA and 
GFP transfected cells. The knockdown efficiency of WIPI4 and overexpression of WIPI4-GFP 
is shown in Fig.3.16F. To summarize, WIPI4 may function together with ATG2, and WIPI4 loss 
of function can be partially masked by overexpression of ATG2 in basal conditions. However, 
more experiments would be required to conclusively demonstrate this. 
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3.3.3 WIPI4 depletion did not change the localization of ATG2-GFP on 
autophagosomes 
The structure analysis of WIPI4 homolog Hsv2 indicates that it has all its membrane binding 
sites on the same side. Therefore WIPI4 may not tether membranes by itself. Instead, it may 
regulate autophagosome closure together with its interactors. The possible mechanisms are: 
1) Recruiting ATG2 onto autophagosomes and facilitate the tethering of isolation 
membrane ends/autophagosomes and lysosomes.  
2) Instead of recruiting ATG2 onto membrane structures, WIPI4 may function with ATG2 
interdependently. 
3) WIPI4 may be required for the recruitment or activity of other closure regulators. 
First, it was examined if WIPI4 recruits ATG2 onto autophagosomes. In yeast, there is 
contradictory evidence about the sequential recruitment of Atg2 and Atg18. Takatori et al. 
2012, claimed that Atg18 is required for the recruitment of Atg2 onto the PAS (phagophore 
assembling site). However, Gómez-Sánchez et al. suggest that the Atg2 association to Atg9 
induces a conformational change that together in the presence of PtsIns3P on 
autophagosomal membranes, promotes the specific recruitment of Atg18. To understand how 
WIPI4 assists ATG2 function in tethering large vesicles, experiments were performed to 
identify if WIPI4 regulates the localization of ATG2 onto autophagosomes and lysosomes.  
If WIPI4 recruits ATG2 onto autophagosomes, WIPI4 knockdown should decrease the 
colocalization of ATG2-GFP and LC3. Fig.3.17 shows that the colocalization of ATG2-GFP 
with LC3 was not changed by WIPI4 knockdown in basal conditions. In parallel, the 
colocalization of ATG2-GFP and LC3 was not changed by WIPI4 knockdown in starvation 
conditions (Fig.3.18). Therefore, WIPI4 is not upstream of ATG2 in the autophagosome closure 
process. Instead, WIPI4 and ATG2 may regulate autophagosome closure interdependently.  
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3.4 Summary of results 
The experiments in this chapter showed that WIPI4 knockdown increased LC3-II by protein 
levels in basal conditions, but did not change that in the presence of BafA1; GFP-RFP-LC3 
reporter assay indicated that the number of autolysosomes decreased. Moreover, the 
clearance of autophagy substrates, both Huntingtin-Q74 and p62-GFP, was slowed down in 
WIPI4 knockdown conditions, implying that the autophagy function is impaired. However, since 
the LC3-II was accumulated as shown by both western blots as well as the number and size 
of LC3-II positive vesicles, WIPI4 loss of function may block the autophagy flux at a step after 
LC3 conjugation. Therefore, all the steps after LC3 conjugation were assessed. It was found 
that WIPI4 loss of function did not stop the autophagosomes leaving the recycling endosomes, 
or their fusion with lysosomes, or the lysosome degradative ability. The left possibilities are the 
late expansion or the closure of phagophores. In addition, loss of function of WIPI4 and ATG2 
affects lysosome acidification differently (Fig.3.10 & 3.19), suggesting that WIPI4 may also 
have other functions independent of ATG2. 
Next, the potential mechanisms of WIPI4 regulating the late stage of autophagosome formation 
were explored. WIPI4 is not required for the recruitment of ATG2, its interactor, onto 
autophagosomes.  
Altogether, the experiments above defined the stage of the autophagy pathway where WIPI4 
functions and found that WIPI4 regulates the late stage of autophagosome formation in basal 
conditions together with ATG2.  
 
  
82 WIPI4 regulates a late stage of autophagosome formation in basal autophagy 
 
 
4.1 WIPI4 regulates GABARAP levels 83 
 
Chapter 4 The mechanism of WIPI4 function in 
autophagy 
The previous chapter illustrates that WIPI4 regulates the late stage of autophagosome 
formation in basal conditions. However, the closure defect was minor compared to that caused 
by ATG2A/B knockdown, suggesting that WIPI4 may have additional functions independent of 
ATG2. Thus, this chapter will explore further the function of WIPI4 in closure and other 
autophagy processes if there are. 
4.1 WIPI4 regulates GABARAP levels 
First, the colocalization of WIPI4 with autophagosome markers was explored to understand 
whether WIPI4 localizes on autophagosomes. To gain clear WIPI4 staining, multiple antibodies 
and cell lines were tested. C2C12 cells give much better WIPI4 staining than in HeLa cells.  
Fig.4.1 demonstrates that WIPI4 colocalizes with ATG8 in both HeLa (Fig.4.1A) and C2C12 
cells (Fig.4.1B), but to a more significant extent with GABARAP. In starved HeLa cells, less 
than 10% of mRFP-LC3 vesicles colocalize with WIPI4-GFP vesicles (Fig.4.1C). Instead, many 
of them are adjacent to each other. As shown by live imaging (Fig.4.1D), mRFP-LC3 vesicles 
were observed to travel around WIPI4-GFP vesicles (observed in two separate experiments).  
GABARAP recruits autophagosome-lysosome tethering regulators (Manil-Ségalen et al., 
2017) (Albanesi et al., 2015), and ATG8 lipidation may accelerate autophagosome closure 
(Tsuboyama et al., 2016), suggesting that GABARAP may function in either or both closure 
and fusion steps, in other words, together or downstream of WIPI4 in the maturation of 
autophagosomes. To investigate this, GABARAP levels in cells depleted of WIPI4 were first 
examined. 
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4.1.1 WIPI4 knockdown decreases GABARAP-I levels  
As shown in Figure 4.2A, GABARAP-I but not GABARAP-II levels were decreased by WIPI4 
knockdown in HeLa cells.  In contrast, LC3-I levels were not changed, and LC3-II levels were 
increased in both basal and starvation conditions (Fig.4.2B). The knockdown efficiency of 
WIPI4 is shown in Figure 4.2C. Similarly, GABARAPL1-I levels were decreased, but 
GABARAPL1-II levels were not significantly altered (Figure 4.3). 
This indicates that WIPI4 regulates the abundance of GABARAP. To understand whether this 
regulation is required for WIPI4 function in autophagy, it was first assessed whether GABARAP 
knockdown phenocopies WIPI4 knockdown regarding LC3 levels and if WIPI4 knockdown still 
blocks autophagic flux in GABARAP depleted conditions. 
4.1.2 GABARAP is required for WIPI4 function 
4.1.2.1 GABARAP knockdown blocks autophagy flux 
Similar to WIPI4 knockdown, the knockdown of GABARAP alone and three GABARAP family 
proteins together increased LC3-II levels in the absence of BafA1 but did not change LC3-II 
levels in the presence of BafA1 (Figure 4.4 A&B). GABARAP-GFP overexpression also 
decreased the percentage of cells containing Htt-Q74 aggregates (Figure 4.4C). This suggests 
that GABARAP functions in late stages of autophagosome formation, downstream of LC3 
conjugation, similar to WIPI4. 
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4.1.2.2 WIPI4 knockdown does not increase LC3-II levels in 
GABARAP triple knockout HeLa cells. 
Figure 4.5 shows that there is no accumulation of LC3-II in GABARAP triple knockout HeLa 
cells transfected with WIPI4 siRNA compared to scrambled siRNA, suggesting that WIPI4 
functions at the same level or upstream of GABARAP.  
The above results confirm the previous hypothesis that WIPI4 functions together or upstream 
of GABARAP in the autophagy pathway.  
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4.1.3 WIPI4 indirectly regulates the subcellular localization of GABARAP 
The next question is how WIPI4 regulates GABARAP and whether this regulation is required 
for closure. Based on the fact that total GABARAP protein levels were reduced by WIPI4 loss 
of function, the autophagy-active GABARAP pool may be regulated by WIPI4:  
i. through regulating GABARAP lipidation;  
ii. through direct interaction with it;  
iii. through indirectly regulating GABARAP subcellular trafficking independent of lipidation.  
It is known that GABARAP and LC3 are lipidated through the same machinery (Zens et al., 
2014), while GABARAP and LC3 are differently regulated by WIPI4 as shown in Figure 4.2, 
suggesting that WIPI4 may not regulate GABARAP through the lipidation machinery.   
Figure 4.6 suggests that WIPI4 does not interact with GABARAP. ATG2 was blotted as a 
positive control for the co-IP experiment. Thus, if WIPI4 regulates the localization of 




92 The mechanism of WIPI4 function in autophagy 
 
4.1.4 WIPI4 does not decrease the autophagosome localization of GABARAP-
II.  
If WIPI4 recruits GABARAP onto autophagosomes, WIPI4 knockdown may decrease the 
number of GABARAP positive vesicles. However, the blockage of autophagy flux accumulates 
and increases the absolute number of autophagosomes, as shown in ATG2AB knockdown 
(Figure 4.7). The accumulation of autophagy markers caused by the blockage of autophagy 
flux may impair the observation of recruitment defects. 
 
To determine if there was a recruitment defect, LC3 and ATG16 were used as internal positive 
controls, since vesicles positive for LC3 and ATG16 accumulate when WIPI4 is knocked down. 
If there is reduced recruitment of GABARAP onto autophagosomes, there should be a 
decrease in the percentage of GABARAP-positive LC3 and ATG16 vesicles out of all LC3 and 
ATG16 vesicles.  However, WIPI4 knockdown did not change the colocalization of GABARAP 
with LC3 or ATG16 (Figure 4.8).  
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4.1.5 WIPI4 regulates the trafficking of GABARAP 
Even with the ATG16 and LC3 internal control, it is not enough to exclude the possibility that 
the block of autophagy flux accumulates GABARAP on autophagosomes. Therefore, the other 
membrane compartments on GABARAP trafficking route was examined to understand whether 
the active GABARAP pool is reduced. 
Joachim reported in 2015 and 2017 that there is an active GABARAP-I reservoir on the 
centrosome satellites which can translocate onto autophagosomes during starvation. When 
the centrosome satellites are abnormally disassembled by PCM1 knockdown, centrosomal 
MIB1 can assess and degrade GABARAP; other centrosomal GABARAP accumulates on 
GM130 positive structures and becomes inactive (Diagram 4.1).  
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Thus, centrosome satellite structures and the colocalization of GABARAPL1 with GM130 were 
examined. GABARAPL1 was similarly decreased in WIPI4 knockdown conditions, as shown 
in Figure 4.2. WIPI4 knockdown reduced the centrosome satellite marker PCM1 in both basal 
and starved conditions (Figure 4.9) and increased the GABARAPL1 colocalization with GM130 
in basal conditions only (Figure 4.10). To summarise, WIPI4 knockdown reduces the active 
GABARAP pool.  
Next, I tried whether rescuing the active GABARAP pool can rescue the block of autophagy 
flux. 
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4.2 WIPI4 knockdown destabilized GABARAP through the 
proteasome pathway 
The decrease of GABARAP-I levels could be caused by either the decrease of transcription / 
translation or an increase in degradation. Cycloheximide treatment experiments suggest that 
GABARAP degradation was increased by WIPI4 knockdown (Figure 11).  
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4.2.1 GABARAP degradation regulated by WIPI4 is proteasome-dependent. 
GABARAP is degraded by both the proteasome and autophagy pathways. To understand 
which pathway is utilised by WIPI4 to regulate GABARAP degradation, the proteasome 
pathway was blocked by MG132. Interestingly, MG132 treatment blocked the increase of 
GABARAP degradation (Figure 12), suggesting that WIPI4 regulates GABARAP levels through 
the proteasome pathway.  
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4.2.2 WIPI4 knockdown increased the proteasome degradation of GABARAP 
WIPI4 knockdown may alter the exposure of GABARAP to specific E3 ligases / DUBs or inhibit 
the proteasome pathway in general. However, WIPI4 knockdown did not significantly increase 
the total levels of ubiquitinated proteins (Figure 4.13). In addition, there is an accumulation of 
ubiquitinated proteins in WIPI4 siRNA, and cycloheximide-treated samples, suggesting that 
the degradation of ubiquitinated proteins was slowed down, possibly by dysfunction of 
autophagy. Moreover, WIPI4 knockdown increased the K48, K63, and total ubiquitination of 
GFP-GABARAP (Figure 4.14). Therefore, WIPI4 may regulate the exposure of GABARAP to 
specific E3 ligases / DUBs.  
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4.3 WIPI4 regulates GABARAP levels through UBR5 
A screen was done to identify E3 ligases targeting GABARAP and regulated by WIPI4 at the 
same time. There are several E3 ligases and DUBs identified by the WIPI4-GFP mass 
spectrometry analysis (see Chapter 3), and WIPI4-GFP was immunoprecipitated to confirm 
their interaction. UBR5 was found to interact with WIPI4 and GABARAP (data in Chapter 3).  
4.3.1 UBR5 interacts more with GABARAP when WIPI4 is depleted 
To test whether the interaction of UBR5 and GABARAP is regulated by WIPI4, GABARAP-
GFP was immunoprecipitated from transiently transfected HeLa cells and blotted for UBR5. As 
shown in Figure 4.15, WIPI4 knockdown increased UBR5 and GABARAP interaction. 
  




4.3.2 UBR5 knockdown rescued the decreased levels of GABARAP caused by 
WIPI4 knockdown 
To understand whether WIPI4 regulates autophagy through the UBR5-GABARAP interaction, 
the rescue of WIPI4 knockdown was explored by knocking down UBR5. MIB1, a published E3 
ligase of GABARAP (Joachim et al., 2017), was knocked down as a positive control. Both MIB1 
and UBR5 knockdown rescued the decrease of GABARAP-I levels in WIPI4 knockdown cells 
(Figure 4.16 A-C). Knockdown of UBR4, an E3 ligase from the same family of UBR5, failed to 
rescue GABARAP levels. This may be relevant to the fact that UBR4 loss of function also 
increases WIPI4 levels while UBR5 loss of function does not regulate WIPI4 levels (Figure 
4.16D).  
  




4.4 Exploration of other autophagosome closure/ maturation 
regulators potentially recruited by WIPI4 onto autophagosomes 
Mass spectrometry analysis was performed to identify other proteins potentially regulated by 
WIPI4. Data will be shown in the next chapter.  
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4.5 Summary of Results 
In this chapter, it is confirmed that GABARAP (L1) functions downstream of WIPI4 and 
upstream of autolysosome degradation. Because: 
i. WIPI4 depletion does not accumulate LC3-II in GABARAP-family knockout cells. 
ii. Depletion of GABARAP family proteins accumulated LC3-II. 
iii. GABARAP (L1) trafficking is disrupted by WIPI4 depletion. 
iv. GABARAP-I and GABRAPL1-I protein levels are decreased by WIPI4 loss of function.  
Moreover, it was confirmed that the WIPI4 regulates GABARAP protein levels through 
regulating its interaction with an E3 ligase, UBR5.  Knockdown of UBR5 and another known 
E3 ligase targeting GABARAP, MIB1, both rescued the decrease of GABARAP levels caused 
by WIPI4 loss of function.  More work is required to understand whether GABARAP regulates 
autophagosome closure or other biological processes downstream of WIPI4.  
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Chapter 5 UBR5 regulates autophagy pathway by 
modulating GABARAP stability 
WIPI4 knockdown decreased GABARAP-I but not GABARAP-II levels due to increased 
degradation of the total GABARAP pool through the proteasome pathway. Therefore, WIPI4 
loss of function may change the activity or the levels of at least one of the following: E3 ligases 
degrading GABARAP, deubiquitylating (DUB) enzymes protecting GABARAP, or general 
proteasome pathway components. Since WIPI4 loss of function did not increase the levels of 
ubiquitinated proteins, it may regulate the exposure of GABARAP to specific E3 ligases or 
DUBs.  
To be able to investigate the components of the ubiquitination pathway affected by WIPI4 
knockdown, E3 ligases and DUBs identified as potential interactors of WIPI4-GFP by Mass 
Spectrometry analysis were screened.  
5.1 Analysis of Mass Spectrometry hits 
The hits that are at least twice (1.5 times if the peptide count is above 100) more abundant in 
WIPI4-GFP samples than in the GFP samples are considered to be potential interactors of 
WIPI4. ATG2 was identified (data not shown), validating that WIPI4 and ATG2 interact with 
each other and that the experiments were technically reliable.  
To understand proteins of which pathways are relatively enriched by WIPI4-GFP compared to 
the human genome, the 206 potential interactors were first clustered by 
http://www.pantherdb.org/. Proteins of catalytic activities including DNA polymerases, 
deubiquitinases, ATPase regulators, chaperone clients and ubiquitin (-like) protein interactors 
were enriched by 32.13, 16.18, 10.62, 7.59 and 5.57 fold each when compared to the human 
genome. In order to identify potential WIPI4 interactors from the UPS pathway, the 206 hits 
were categorized according to the biological processes they function in by 
https://david.ncifcrf.gov/home.jsp and https://string-db.org/. As shown in Figure 1A, 
Proteasome subunits were found with high abundance in WIPI4-GFP overexpressed samples. 
Two E3 ligases，UBR4 (20:0), UBR5 (18:0), and one DUB，USP9x (5:0), which are most 
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enriched by WIPI4-GFP according to the peptide count, were examined first. Additionally, MIB1 
was considered since it has been reported as a GABARAP E3 ligase (Joachim et al., 2017). 
Figure 1B showed other membrane-binding proteins identified and will be discussed in the 
discussion later. 
  
108 UBR5 regulates autophagy pathway by modulating GABARAP stability 
 
 
5.2 UBR5 interacts with GABARAP 
To identify the potential regulators of GABARAP which interact with WIPI4, WIPI4-GFP and 
GABARAP-GFP were pulled down separately as bait proteins for immunoprecipitation. As 
shown in Figure 2A, MIB1 and UBR4 did not co-precipitate with WIPI4-GFP (Figure 5.2A), 
although MIB1 was pulled down with GABARAP-GFP. UBR5 and USP9x interacted with both 
WIPI4-GFP and GABARAP-GFP (Figure 5.2 A&B). A trace amount of USP9x was 
immunoprecipitated with GFP protein in the control sample suggesting that USP9x binds to 
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WIPI4-GFP and GABARAP-GFP partially through the GFP tag rather than specifically with 
WIPI4 and GABARAP. Hence, I focused on UBR5 because it not only interacts with GABARAP 
but also interacts with WIPI4.  
Interestingly, UBR5 immunoprecipitated much less with GFP-LC3 compared to that with GFP-
GABARAP (Figure 5.3A). Moreover, UBR5 interacts with GABARAP in both wildtype and 
autophagy-null cells (ATG16 knockout cells) in both basal and starved conditions (Figure 
5.3B). Experiments in ATG16-null cells which confirmed the GABARAP-UBR5 interaction 
suggests that this interaction is with GABARAP that is not conjugated to lipid (GABARAP-I) 
since lipidation does not occur in these cells (Bento et al., 2016).  
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5.3 UBR5 negatively regulates GABARAP-I levels 
The immunoprecipitation experiment results suggest that UBR5 interacts with GABARAP, 
which is consistent with the hypothesis that UBR5 is an E3 ligase of GABARAP. To corroborate 
this hypothesis, UBR5 should negatively regulate GABARAP protein levels post-
transcriptionally and should ubiquitinate GABARAP in vivo and in vitro.  
5.3.1 UBR5 siRNA treatment increased GABARAP-I levels  
UBR4 is from the same E3 ligase family as UBR5 and may have similar activity to UBR5. 
However, UBR4 was not shown to interact with GABARAP, but its molecular weight of 600 
kDa may have affected the efficiency of the co-IP experiment. Therefore, the effect on 
GABARAP levels of UBR4 and UBR5 knockdown was assessed separately. Figure 5.4A 
shows that both UBR4 and UBR5 siRNA knockdown in HeLa cells significantly increased 
endogenous GABARAP-I levels under basal conditions. UBR4 knockdown also increased 
GABARAP-II levels. However, there was only a slight, but not significant increase of 
GABARAP-II levels in UBR5 siRNA treated cells. WIPI4 knockdown decreased GABARAP-I 
as discussed in Chapter 4. The knockdown efficiency of UBR4, WIPI4 and UBR5 is shown 
below. If UBR5 downregulates GABARAP-I levels directly rather than through autophagy, it 
should perform the same function in autophagy-null cells. UBR5 knockdown increased 
GABARAP-I levels in both wild type and ATG16 KO HeLa cells in both fed and starvation 
conditions (Figure 5.4B). The bands above GABARAP-I bands may be GABARAP with other 
modifications.  
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5.3.2 UBR5 loss of function inhibits GABARAP degradation 
Since UBR5 has been reported to play a role in the transcription regulation (Flack et al., 2017), 
there was a question about whether UBR5 transcriptionally inhibits the expression of 
GABARAP or destabilises the GABARAP protein. HeLa cells were treated with cycloheximide 
in combination with the control and UBR5 siRNAs. UBR5 knockdown slowed down the 
degradation of both endogenous GABARAP-I (Figure 5.5A) and overexpressed nEGFP-
GABARAP-I (Figure 5.5B) during 5-hour treatment. UBR4 siRNA treated samples showed a 
similar trend. Two other members of GABARAP family, GATE-16 and GABARAPL1, were 
similarly protected from degradation by UBR5 and UBR4 knockdown (Figure 5.5A).  Although 
UBR5 interacts with WIPI4, it does not regulate the protein levels of WIPI4 (Figure 3.16.C&D, 
Chapter 3). 
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To check whether the increase of GABARAP-I levels was specifically caused by UBR5 
knockdown or off-target effects of UBR5 SMARTpool siRNA, HeLa cells were treated with 
UBR5 deconvoluted siRNAs, and GABARAP protein levels were analysed by western blots. 
Figure 5.6 demonstrates that knockdown by every deconvoluted oligo significantly increased 
the levels of GABARAP-I in basal conditions. Furthermore, every oligo knocked down UBR5 
efficiently to a similar degree, suggesting that the increase of GABARAP-I levels was 
specifically caused by UBR5 knockdown.  
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5.3.3 Transient transfection of wild type UBR5 decreased GABARAP-I levels 
compared to the UBR5 catalytically dead construct 
If UBR5 is an E3 ligase for GABARAP, its overexpression should decrease GABARAP protein 
levels. Wildtype UBR5 and the catalytic dead mutant of UBR5 (2768 cysteine mutated to 
alanine, hereafter as UBR5-C2768A) constructs were transfected into HEK293 cells 
separately. As shown in Figure 5.7A, GABARAP-I levels in cells expressing Flag-UBR5-His 
were lower than that in Flag-UBR5-C3768A-His samples. To summarize, wildtype UBR5 
protein decreased GABARA-I protein levels compared to the catalytic dead UBR5 mutant. 
Consistently, GFP-UBR5 overexpression decreased GABARAP-I levels in HEK293 cells 
compared to GFP-UBR5-C2768A (Figure 5.7B). Taken together, UBR5 overexpression 
decreases GABARAP-I levels.  
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5.4 UBR5 directly ubiquitinates GABARAP 
5.4.1 UBR5 loss of function decreased ubiquitination levels of GABARAP in 
vivo 
If UBR5 degrades GABARAP through the proteasome pathway, GABARAP should be less 
ubiquitinated in cells depleted of UBR5. To verify this, HeLa cells were transfected with nGFP-
GABARAP in combination with K63-linked HA-Ubiquitin or K48-linked HA-Ubiquitin constructs. 
Recombinant nGFP-GABARAP was immunoprecipitated with GFP-Trap Dynabeads, and the 
HA-ubiquitin conjugated onto them was analysed by western blots. As demonstrated in Figure 
5.8, immunoprecipitated nGFP-GABARAP was less conjugated with both K63 and K48 
ubiquitin chains in UBR5 siRNA-treated HeLa cells. UBR5 loss of function also reduces greatly 
the K48 and K63 in the inputs, which is consistent with previous literature that UBR5 is involved 
in ubiquitination of many proteins and peptides and is one of the most important K48 ubiquitin 
conjugators (Yau et al., 2017).  
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5.4.2 UBR5 ubiquitinates GABARAP in vitro 
In vitro ubiquitination assays were performed to examine whether UBR5 directly ubiquitinates 
GABARAP. Flag-UBR5 and Flag-UBR5-C2768A were purified separately from HEK293 cells 
transiently transfected with UBR5 constructs. Cells transiently transfected with CMV-Flag 
constructs were processed by the same protocol, and the elution was used as a negative 
control. His-GABARAP protein was used as the substrate.   
According to Figure 5.9A, GABARAP staining showed several bands of high molecular 
weight in the sample of wild type UBR5, while in the Flag control sample the staining is much 
less, suggesting that Flag-UBR5 increased the molecular weight of proteins which contained 
GABARAP, possibly GABARAP conjugated with ubiquitin molecules, as confirmed by the 
K48 staining of the same samples re-run on another gel (Figure 5.9A). 
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Figure 5.8B shows multiple ubiquitinated GABARAP (GABARAP-(Ub)n) signals in only two 
reaction products with wild type Flag-UBR5 (Lanes 6 & 7). The quantity correlates to the 
amount of E1 added, indicating that the signal is produced by a ubiquitination reaction and the 
E1 concentration is not over saturated. The levels of UBR5 proteins in the elutes used in these 
experiments are shown in Figure 5.9C. 
Similarly, Figure 5.9D demonstrates that the GABARAP signal is stronger at high molecular 
weight sections of the membrane in the Flag-UBR5 reaction product (Lane 2) than the UBR5-
C2768A mutant reaction products (Lanes 3 and 4), although there is much less wild type UBR5 
protein than UBR5-C2768A protein. Therefore, the enzymatic activity of UBR5 is required for 
the reaction. Also, the GABARAP signal overlaps partially with K48 ubiquitin signal, indicating 
that this staining is probably ubiquitinated GABARAP. Although the GABARAP staining may 
be both from His-GABARAP and endogenous GABARAP pulled down together with UBR5, 
there is no GABARAP-(Ub)n signal in the no E1 control (Lane 1). This implies that the 
GABARAP-(Ub)n signal is produced by the in vitro ubiquitination reaction. Taken together, 
UBR5 ubiquitinates GABARAP in vitro. 
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5.5 Identification of the lysine’s modified by UBR5  
5.5.1 The N-degron mutated and lipidation insensitive GABARAP mutant (K2P-
G116A-GABARAP-cGFP) is less ubiquitinated than the lipidation insensitive 
GABARAP mutant (G116A-GABARAP-cGFP) 
UBR5 is a UBR-box family E3 ligase, which recognizes destabilizing N-terminal residues (N-
degrons) by the UBR-box. This recognition may be required or helpful for their interaction. If 
UBR5 ubiquitinates GABARAP following the N-end rule mechanism, the second lysine on 
GABARAP should be an N-degron. To test whether the second-lysine is involved in the 
ubiquitination of GABARAP, an N-degron mutated and lipidation insensitive GABARAP-cGFP 
construct (GABARAP-k2P-G116A-cGFP) was made and transiently expressed in HeLa cells 
to examine its interaction with UBR5. Lipidation insensitive GABARAP-G116A-cGFP was 
made as a control (Figure 5.10). The GFP tag was added onto the c-terminal because it was 
unknown whether an N-terminal GFP tag would block the interaction of UBR-box and the N-
degron. To avoid the c-cGFP tag from being cleaved off by ATG4, the glycine which would be 
recognized by ATG4 was mutated to alanine.  
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Consistent with the hypothesis that GABARAP is an N-end-rule pathway substrate, 
immunoprecipitated K2P-G116A-GABARAP-cGFP was less K48-ubiquitinated than G116A-
GABARAP-cGFP in GABARAP-subfamily triple knockout HeLa cells, both with endogenous 
ubiquitin and overexpressed HA-ubiquitin (Figure 5.11). Thus, the N-degron of GABARAP 
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5.5.2 ATE1 loss of function increased GABARAP levels 
Based on the principle of N-end rule, GABARAP has primary N-degrons, rather than a 
penultimate amino acid that can be processed to be secondary/ tertiary N-degrons. To 
understand whether this applies to the recognition of UBR5 of GABARAP, I tested whether 
ATE1 function affects GABARAP stability. As ATE1 is required for the generation of secondary 
N-degrons, its loss of function should not change GABARAP protein stability. Surprisingly, 
ATE1 siRNA treatment in HeLa cells increased GABARAP-I and GABARAP-II levels (Figure 
5.12A). However, LC3 levels were similarly increased by ATE1 knockdown (Figure 5.12B) 
although LC3 does not have an N-degron. Therefore, with the assumption that ATE1 siRNA 
has no off-target effects, ATE1 regulates LC3 and GABARAP levels indirectly, rather than 
directly regulating the stability of GABARAP proteins through the N-end rule pathway.  
Conclusively, this experiment cannot reveal whether UBR5 recognises GABARAP through 
primary degrons or secondary/ tertiary N-degrons, but rather raised another scientific question 
of how ATE1 regulates autophagy. 
  
5.5 Identification of the lysine’s modified by UBR5 125 
 
5.5.3 Mass Spectrometry analysis results indicated that K35 and K24 of 
G116A-GABARAP-cGFP but not the K2P-G116A-GABARAP-cGFP are subjected 
to ubiquitination. 
Two groups of post-transcription-modification Mass Spec analyses were done to identify poly-
ubiquitination sites specific for UBR5: 
Group 1: K2P-G116A-GABARAP-cGFP (KP) and G116A-GABARAP-cGFP (GA) 
If UBR5 follows the N-end rule when it ubiquitinates GABARAP, KP mutant should be less 
ubiquitinated on certain lysines compared to GA control. 
Group 2: G116A-GABARAP-cGFP, control or UBR5 siRNA 
If UBR5-GABARAP ubiquitination does follow the N-end rule, the G116A-GABARAP-cGFP in 
control siRNA treated samples should be more ubiquitinated on certain lysines compared to 
that in the UBR5 siRNA treated group. 
Experiments were performed in HeLa ATG8 Hexa knockout cells (HeLa cell line knocked out 
of all ATG8 family proteins by CRISPR-Cas9, a kind gift from Michael Lazarou) because the 
ubiquitination would be focused on the overexpressed GABARAP protein when the 
endogenous ATG8 proteins are absent. GFP-trap immunoprecipitation products were 
submitted for Mass Spectrometry analysis. The results of the Group 1 analysis suggest that 
K35 and K24 were ubiquitinated only in G116A-GABARAP-cGFP, not in K2P-G116A-
GABARAP-cGFP. In comparison, K6 was only ubiquitinated in K2P-G116A-GABARAP-cGFP, 
not in G116A-GABARAP-cGFP. K35 modification is of higher confidence than that of K24 and 
K6 (Figure 5.13).  
Since the results of Group 1 suggested that the N-degron changed the ubiquitination status of 
GABARAP, the analysis of Group 2 samples was cancelled.  
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5.6 Summary of results 
UBR5, an N-recognin, interacts with both WIPI4 and GABARAP as verified by 
immunoprecipitation. It negatively regulates the protein level of GABARAP family proteins by 
promoting their degradation. In vitro ubiquitination assays confirmed that UBR5 ubiquitinates 
GABARAP with K48-linked ubiquitin chain, and UBR5 loss of function in vivo reduced both 
K48/K63-linked ubiquitination of NGFP-GABARAP proteins. Moreover, mutation of the lysine 
at Position 2 to proline reduced the K48-linked ubiquitination of GABARAP-GA-cGFP protein, 
suggesting that the N-degron of GABARAP may improve the ubiquitination of GABARAP. 
Further, Mass spec analysis identified two potential ubiquitination sites that are only modified 
on N-degron-present GABARAP protein, implying that they are potential internal degrons 
recognized by UBR5. Further experiments are required for the confirmation of these 
ubiquitination sites. For example, mutations at K35 and K24 may be used to test whether their 
mutation prevented ubiquitination of GABARAP and extended its half-life. 
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Chapter 6 Discussion 
This thesis explored the function of WIPI4 in autophagy and found that WIPI4 regulates 
autophagosome closure as well as the stability and trafficking of GABARAP, another 
autophagy protein downstream of it. Given that ATG8 proteins were the only known machinery 
triggering the autophagosome closure while working on this project, this thesis further explored 
the possibility of it regulating the autophagosome closure downstream of WIPI4. This 
discussion will first summarize the current understanding and suggest future research 
directions about WIPI4 function in autophagy based on findings in this thesis and the very 
recent literature.  
The second section will cover the open questions about how UBR5 regulates GABARAP. 
UBR5 is a novel N-recognin E3 ligase for GABARAP, which is subject to the regulation of 
WIPI4. Consistent with this function, the N-degron of GABARAP promotes its ubiquitination.  
6.1 The function of WIPI4 
6.1.1 ATG2-dependent functions 
Given that the overexpression of WIPI4-GFP and ATG2-GFP separately increased LC3-II 
levels in control cells (Chapter 3, Figure 3.16 B&D), and that HEK293 cells lacking endogenous 
ATG2A/B also accumulated LC3-II (Tamura et al., 2017), WIPI4 and ATG2 appear to function 
synergistically in both overexpression and loss-of-function conditions. Moreover, ATG2 loss of 
function reduced WIPI4 levels but not vice versa (Figure 6.1). This suggests that ATG2 is the 
major component of the WIPI4-ATG2 complex. In vitro analysis showed that one of the 
functions of WIPI4 is to form a complex with ATG2 and that this interaction stabilized the 
interaction of ATG2 with PI3P containing vesicles.  
The N-terminal fragment of ATG2, which has no tethering domains, still rescues the autophagy 
defect of the ATG2 KO cell line (Osawa et al., 2019), suggesting that the lipid transfer function 
of ATG2 is responsible for its main function in autophagy.  
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6.1.1.1 Promoting ATG2 function in the late stage of autophagosome formation 
The lipid transfer function of WIPI4-ATG2 complex may facilitate the recruitment of certain 
lipids and proteins which drives maturation of autophagosomes. To be specific, the ATG2-
WIPI4 complex may maintain or change the lipid composition of phagophores by non-vesicular 
transport. This may lead to: 
i. Stability or change of physical properties of membranes, e.g. curvature/ fluidity.  
ii. Stability or change of downstream lipid effectors, which may be closure/maturation 
modulators. 
Identification of the modulators potentially recruited will help shed light on the mechanism of 
WIPI4-ATG2 in autophagosome closure. An analysis of proteins/lipids on vesicles that 
accumulate in cells depleted of WIPI4, as well as proteins enriched on autophagosomes in WT 
but not WIPI4 loss of function conditions, may help identify the closure regulators recruited by 
WIPI4-ATG2 complex.  
Lipid transfer proteins are usually first defined by highly controlled in vitro experiments. 
Evidence of the same reactions in cells is required to support the functional relevance. 
However, the in vivo techniques for studying lipid transport pathways are currently limited. For 
example, deletion of certain lipid transfer proteins may induce cellular adaptations, in particular 
by hypertrophy of parallel pathways. In such a circular environment, blocking any of the steps 
leads to hypertrophy of other routes. Therefore, although it is uncontroversial that ATG2 and 
WIPI4 mediate net lipid traffic, it might be much harder to determine whether the rates of in 
vivo lipid traffic are affected by ATG2 and WIPI4 levels. In vivo function analysis in this thesis 
helped understand the exact biological process and provided implications about other potential 
interactors in that process 
6.1.1.2 Inhibition/ adjusting the lipid transfer function of ATG2 
However, if the function of WIPI4 is simply to assist ATG2’s lipid transfer function in expanding 
the phagophores, WIPI4 loss of function should cause similar defect with ATG2 loss of 
function. In contrast, multiple evidence suggests that WIPI4 may also inhibit/ adjust the lipid 
transfer function of ATG2: 
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i. WIPI4 loss-of-function increased the size of autophagosomes in HeLa cells; while 
ATG2 loss of function reduced the size of autophagosomes dramatically in U2OS cells. 
The smaller autophagosomes can still mature into autolysosomes (Tang et al., 2019). 
ii. WIPI4 loss-of-function only slightly increased the ratio of proteinase K sensitive LC3-II 
out of the total LC3-II, while ATG2 loss of function greatly increased the ratio. This 
suggests that the proteinase K assay, although designed to test the closure defect, 
may mainly reflect the expansion defect and changes of autophagosome size rather 
than the closure defect, as ATG2 has been proved to be a regulator of expansion, 
rather than closure. 
iii. HeLa cells still respond to BafA1 treatment when WIPI4 is depleted (Chapter 3, Figure 
3.1&3.2), while ATG2-depleted HEK293 cells cannot (Valverde et al., 2019; Tang et 
al., 2019). This suggests that WIPI4 functions later than ATG2 in a late stage of 
phagophore expansion, and it is not clear whether there is closure defect. 
 
The difference of the proportion of proteinase K cleavable LC3-II out of total LC3-II in WIPI4 
and ATG2 depleted cells may be caused by the increase of the size of autophagosomes. 
Because the total surface area of bigger autophagosomes is less compared to that of the 
smaller autophagosomes formed by the same amount of materials.  
In addition, the observations in Chapter 3 suggests that WIPI4 is not required for the 
autophagosome localization of ATG2. WIPI4 may stabilize the tethering of PI3P containing 
membranes by ATG2 C-termini only after ATG2 binds to phagophores, but may not be the only 
protein able to recruit ATG2 onto autophagosomes. ATG9, for example, regulates the PAS 
localization of ATG2. 
Therefore, the main function of WIPI4 may be to ‘tell’ ATG2 when to stop expansion and 
proceed to closure; without WIPI4, ATG2 may exist overlong on autophagosomes and inject 
more lipid of wrong types to generate bigger but less functional autophagosomes with the 
wrong composition of lipid, or impair ATG proteins like ATG9 to exit in time from 
autophagosomes. 
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6.1.1.3 Expansion defects may indirectly impair closure  
While working on this project, the other cases reported to impair autophagosome, in addition 
to WIPI4-ATG2 complex, are all indirect and not specific to the closure step. The first one is 
the ATG4B mutant, which increases the ratio of unsealed autophagosomes and the number 
of all autophagosomes through sequestering unlipidated LC3 (Fujita et al., 2009). The second 
is depletion of the ATG8 lipidation system (Tsuboyama et al., 2016), which increases the time 
for autophagosomes to breakdown. The third is an excess of sphingolipids, which accumulates 
ATG9 at non-autophagy compartments (Corcelle-Termeau et al., 2016). However, Corcelle-
Termeau and his colleagues observed unsealed autophagosomes by EM but did not confirm 
with proteinase K protection experiment or quantification of EM images. All of the proteins 
mentioned have known roles in phagophore expansion and are not specific to closure, similar 
to the yeast Atg2-Atg18 complex. The former two (ATG4B and ATG8 lipidation system) both 
impact the ATG8 family proteins. However, ATG8 family proteins accelerate the closure but 
are not required for that, and the mechanism whereby they accelerate the closure is unknown, 
with biophysical evidence pointing to either tethering or fusion.  It is unknown whether tethering 
of the edges of the membranes also promotes the closure, and the in vitro evidence showing 
ATG8 proteins regulate membrane fusion need further analysis. Therefore, ATG8 proteins may 
accelerate the closure of phagophores directly or indirectly, but was the only known machinery 
while working on this project. 
6.1.1.3.1 Whether GABARAP is a closure regulator downstream of WIPI4 
Reports that ATG8 proteins are not required for but accelerate the closure (Tsuboyama et al., 
2016), and GABARAP family and ATG8 family knockout cell lines have only closure defect in 
basal conditions but not in starvation plus BafA1 conditions (Nguyen et al., 2016) by proteinase 
K assay, suggest that GABARAP may play a supportive role in closure but is not required. This 
thesis tested GABARAP because WIPI4 depletion also causes a relatively minor defect in 
closure and ATG8 proteins were the only known potential closure machinery at that moment. 
However, GABARAP still colocalizes with autophagosome marker ATG16, and LC3 in WIPI4 
depleted cells. Although this might be an artefact of impairment of GABARAP dissociation from 
the membrane caused by the block of autophagy flux, it suggests that the presence of 
GABARAP on the membrane is not enough to promote closure. Preliminary experiments 
rescuing GABARAP protein levels with MIB1 or UBR5 knockdown cannot rescue the 
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accumulation of LC3-II in WIPI4 depleted cells (data not shown). Therefore, WIPI4 depletion 
may also disrupt other processes in addition to decrease GABARAP levels. 
The fragmented TGN structures in WIPI4 knockdown conditions (Fig.6.2) suggest that WIPI4 
may regulate not only GABARAP trafficking but also vesicular trafficking in general. Future 
work will first examine whether mis-trafficking of GABARAP or defects of general vesicular 
trafficking accounts for the defect. 
GABARAP is reported to recruit a series of autophagosome-lysosome tethering regulators 
onto autophagosomes: PI4K2A/PI4KIIα need to be recruited from the TGN onto 
autophagosomes by GABARAP; BRUCE and PLEKHM1 both promote the tethering of 
autophagosomes with lysosomes by interacting with GABARAP. The RAB7 effector RMC1 
also accumulates in GABARAP family protein depleted cells (Vaites et al., 2019). There is no 
report about GABARAP recruiting closure regulators. However, Rab5 is reported recently to 
regulate autophagosome closure by facilitating the interaction of ESCRTIII complex subunit 
Snf7 with Atg17 (yeast FIP200) in yeast (Zhou 2019). Interestingly, FIP200 is a subunit of 
ULK1 complex, and all subunits in that complex (ULK1, FIP200 and ATG13) preferentially bind 
GABARAP subfamily members (Joachim 2015). FIP200 also binds WIPI3 (Bakula  et al., 
2017). Further research may explore whether GABARAP regulates the trafficking of closure 
regulators, e.g. ESCRT complex components, Rab5 effectors, and so on. If not, the mis-
trafficking of GABARAP may be a side-effect of the blockage of autophagy flux. The work will 
be redirected onto whether WIPI4-ATG2 regulates the trafficking of closure regulators 
independent of GABARAP.  
6.1.1.3.2 ESCRT complex may be recruited by expansion regulators 
WIPI4 may indirectly regulate closure by regulating the ESCRT-III complex and its regulators 
during the late expansion. No ESCRT-III or Rab5 related proteins were identified by the WIPI4 
Mass Spec, suggesting that either there are unknown ESCRT-III regulators or WIPI4 regulates 
ESCRT-III/Rab5 complexes indirectly.  
Additionally, according to the Mass Spec results (Chapter 5) and as confirmed by Bakula in 
2017, WIPI4 interacts with the nuclear migration protein (NUDC), an Hsp90 co-chaperone that 
stabilizes actin organisation modulator Cofilin 1 (Zhang 2016). Also, it was observed that WIPI4 
loss of function disrupted centrosome satellites (Chapter 4). Interestingly, microtubule is 
required for the constriction function of ESCRT-III in membrane fission (Kharkwal et al., 2014). 
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Therefore, it is possible that WIPI4 also facilitates the constriction function of the ESCRT-III 
complex through regulating microtubule organisation.  
6.1.2 ATG2-independent functions 
The regulation of lysosomes by WIPI4 seems to be independent of ATG2. WIPI4 loss of 
function increased the lysosome pH in basal and starvation conditions (Chapter 3, Figure 3.10), 
while ATG2A/B depletion did not increase the pH of lysosomes (Chapter 3, Figure 3.19). 
Consistent with the observation in mammalian cells, Atg2 is not involved in lysosome 
fragmentation in yeast (Navin et al., 2017), while Atg18, one of the yeast homologs of WIPIs, 
has been reported to trigger the scission of lysosome-like vacuoles through inserting an 
amphipathic 𝛼-helix into the membrane and self-oligomerization (Gopaldass et al. 2017). This 
regulation of Atg18 on vacuole fragmentation is dependent on PI(3,5)P2, not PI3P, suggesting 
that this is an autophagy-independent function. WIPI4 loss of function caused ER stress 
independent on the ERphagy pathway (Wan et al., 2019). As shown in Figure 6.2, the Trans 
Golgi marker TGN46 was greatly dispersed by WIPI4 knockdown, these structures are either 
fragmented Golgi structures (reviewed in Machamer et al., 2015), or vesicles failed to dock on 
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6.1.3 Identification of the WIPI4 function in autophagy helps to understand the 
BPAN pathology 
Iron accumulation in the basal ganglia represents a common hallmark between the different 
classes of NBIA (Arber et al., 2016). The fibroblasts from BPAN patients are of higher levels 
of ferrous iron transporter without the iron response element ((−)IRE/DMT1) and decreased 
levels of transferrin receptor (TfR) than in healthy controls, which suggests intracellular ferrous 
iron overload and an increased risk of iron accumulation (Ingrassia et al., 2017). The 
dysregulation of iron metabolism was corroborated by another study that BPAN patients’ 
fibroblasts and neurons are of decreased ferritin levels and higher iron levels (Seibler et al., 
2018). The aberration of (-)IRE/DMT1 and TfR levels in BPAN patients was further induced by 
starvation (Ingrassia et al., 2017), indicating that WIPI4 may balance intracellular ferrous iron 
levels by degrading (-)IRE/DMT1 through autophagy. Moreover, WIPI4 loss of function induced 
multiple pathological alterations and higher oxidative stress in fibroblasts and neurons of BPAN 
patients, as shown by decreased mitochondrial membrane potential, reduced production of 
ATP, reduced LAMP1 and LAMP2, and elevated levels of superoxide dismutase 2 (SOD2) 
(Seibler et al., 2018).  
It is still unknown which peculiarity is upstream: the defect in iron metabolism or autophagy. 
One fact manifesting the role of iron metabolism pathway in BPAN pathology is that all BPAN 
patients are found with strong iron deposition in the substantia nigra (SN) and globus pallidus 
(GP), while only a subset of Parkinson’s disease patients are found with iron deposition. 
Interestingly, BPAN patients are subject to the degeneration of a bigger brain region, including 
important dopamine receiving cells, bigger than those affected in PD. PD is caused by 
degeneration of cells in the substantia nigra and a subsequent reduction of dopamine in the 
brain, and the administration of the l-isomer of 3,4-dihydroxyphenylalanine (l-DOPA), a 
dopamine precursor (Triarhou et al., 2002), is an effective treatment of PD. In contrast, BPAN 
patients do not respond to similar administration. Lately, ferritinophagy provides a novel link 
between iron homeostasis dysfunction and autophagy impairment. Iron deposition leads to 
defective autophagy, as well as increased α-synuclein levels and ROS, in both primary 
dopaminergic neurons and SH-SY5Y cells (Wan et al., 2017). 
However, the role of WIPI4 in iron metabolism is not required for developing mobility and 
cognitive impairments. CNS-specific Wdr45 knockout (Nes-Wdr45fl/Y) mice recapitulate 
impaired motor coordination, axon swelling and cognitive defects of BPAN patients, but not 
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iron accumulation, suggesting that the role of WIPI4 in iron trafficking in human is absent in 
mice (Zhao et al. 2015).  
Altogether, WIPI4’s function in autophagy seems more important for understanding BPAN 
pathology. This thesis helps shed light on the pathology of BPAN by narrowing down the 
function of WIPI4 in basal and starvation-induced autophagy to late expansion and closure.   
 
6.2 UBR5 is a potential E3 ligase of GABARAP 
The mutation of the lysine at Position 2 of GABARAP sequence protected GABARAP from 
degradation, suggesting that GABARAP may be an N-end rule substrate. Since UBR5 
interacts with and negatively regulates GABARAP levels, UBR5 is very likely an E3 ligase that 
specifically ubiquitinates GABARAP, which has been verified preliminarily by in vitro 
ubiquitination assays. 
Although GABARAP has been found to interact with several E3 ligases to regulate 
macroautophagy or mitophagy (Behrends et al., 2015; Ambivero et al. 2014; Poetsch et al., 
2018), there has been only one E3 ligase, MIB1, reported degrading GABARAP. There have 
been no previous publications suggesting that UBR5 functions in autophagy. In addition, since 
GABARAP is required for autophagy, UBR5 might play dual roles in both proteasome and 
autophagic pathways. Therefore, it will be of both novelty and importance to elucidate the 
function that UBR5 and GABARAP play together. 
Future work is to identify poly-ubiquitination sites on GABARAP that are recognized by UBR5. 
Mass spec analyses indicate that K35 and K24 are not ubiquitinated when the N-degron of 
GABARAP is mutated, suggesting that they may be modified by the N-end rule pathway E3 
ligases. To assess this possibility, ubiquitination levels of K35R mutated GABARAP, K24R 
mutated GABARAP, and K35R-K24R double mutated GABARAP proteins will be evaluated by 
immunoprecipitation. The mutant(s) with lower ubiquitination levels may be possible 
ubiquitination sites of UBR5. Interestingly, K35 is only conserved among GABARAP subfamily 
proteins but cannot be found in LC3 subfamily proteins; K24 is only conserved among 
GABARAP subfamily proteins and LC3C (GATE16); K6 is conserved among all proteins in the 
mammalian ATG8 family. This suggests that when the N-terminal of GABARAP is mutated to 
the same as the N-terminal of LC3, the preferred position for ubiquitin modification of 
GABARAP is changed to a lysine shared by LC3 and GABARAP.  
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In addition to the ubiquitination sites, there are several other questions worth considering. 
6.2.1 The possible interacting site of UBR5 and GABARAP 
Preliminary data shows that the mutation of the N-degron of GABARAP does not decrease its 
interaction with UBR5 (data not shown) but decreased its ubiquitination levels, suggesting that 
the N-degron of GABARAP is not required its interaction with UBR5. Instead, there are other 
mechanisms facilitating UBR5-GABARAP interaction. Other possible mechanisms facilitating 
the interaction between UBR5 and GABARAP include:  
i. Hydrophobic pockets on GABARAP with potential LIR domain on UBR5,  
ii. UIM docking sites found on GABARAP with potential ubiquitin-interacting motif (UIM)-like 
sequences on UBR5 (Vierstra et al., 2019).  
In addition, as shown in Chapter 5 (Figure 5.2C), more UBR5 is immunoprecipitated by GFP-
GABARAP compared to GFP-LC3. However, further experiments are required to understand 
whether UBR5 preferentially binds GABARAP, or simply because the proportion of cytosolic 
GABARAP-I (possibly more approachable for UBR5) to membrane-bound GABARAP-II is 
much higher than that of LC3 in HeLa cells.  Co-IP of UBR5 with GFP tagged GABARAP, and 
LC3 proteins in autophagy-null cells (ATG16 knockout HeLa) may help evaluate the above 
hypotheses. If there is still more UBR5 pulled down by GABARAP compared to LC3, UBR5 
may interact more stably with GABARAP. These experiments will help understand the 
interaction mechanism of UBR5 with GABARAP.  
6.2.2 ATE1, another component of the N-end rule pathway, regulates 
autophagy 
Both GABARAP and LC3 levels were increased by ATE1 knockdown, although according to 
N-end rule, neither should be processed by ATE-1 for degradation. If ATE1 siRNA did not 
cause off-target effect, this suggests one of the two possibilities:  
i. ATE1 indirectly affects their levels by regulating the stability of their positive regulators; 
ii. The degradation intermediates exposed to the internal degrons are recognized by the 




The latter possibility is consistent with the previous understanding that the N-end rule pathway 
is important for the degradation of peptides and protein fragments. For example, C-terminal 
fragments of PINK1 are degraded by the N-end rule pathway (Youle et al., 2013). However, 
this does not contradict the hypothesis that UBR5 degrades full-length GABARAP protein. 
There has been research showing that full length proteins are UBR5 substrates, including the 
DNA damage response protein RNF168 (Gudjonsson et al., 2012), ATMIN (Zhang et al., 
2014), transcription factors pregnane X receptor (Ong et al., 2014), translational machinery 
CDK9 (Cojocaru et al., 2011), PAIP2 (Yoshida et al., 2006), the KATNA1 subunit of the cell 
cycle-related protein KATANIN (Maddika et al., 2009) and the rate-limiting enzyme in 
gluconeogenesis PEPCK (Jiang et al., 2011). 
6.2.3 UBR5 is associated with familial adult myoclonic epilepsy 1 (FAME1) 
c.5720G>A mutation (p.Arg1907His) in the UBR5 gene was found to be associated with 
familial adult myoclonic epilepsy 1, which is linked to 8q24. FAME is a heterogeneous disorder, 
and distinct phenotypic traits might reflect different genetic mutations, although in most cases 
Purkinje cell changes were observed (Rootselaar AF et al., 2007). Cen et al. considered the 
presence of TTTTA and TTTCA expansion repeats to be the founder effect linked to the 
FAME1 locus. Different from their opinion, Ende et al. think the candidate genes are involved 
in Purkinje cell outgrowth or encoding for ion channels or neurotransmitters. For example, a 
gain of function mutation in the ADRA2B (adrenoceptor alpha 2B) gene found in Italian patients 
could potentially reduce gamma-aminobutyric acid (GABA) neurotransmission (Fusco et al., 
2014). A reduction in cortical GABA neurotransmission is associated with cortical myoclonus 
in rats (Ganos et al., 2014). Treatment with anti-epileptic drugs (AEDs) increasing GABA 
neurotransmitter levels can relieve the symptoms (White et al., 2007). In addition, UBR5 has 
been identified to interact with GABAA ρ receptor (Wang et al., 2013) by another group with 
Mass spec. The results in this thesis, together with the above studies, presenting one 
possibility that UBR5 mutation increases the risk of a subtype of FAME through changing the 
stability of GABAA receptors or interactors of GABAA  receptors. More evidence is required to 
confirm or turn down the relevance of UBR5 with GABA transmission and FAME.  
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Abbreviations 
(−)IRE/DMT1: ferrous iron transporter without the 
iron response element 
3-MA: 3-methyladenine 
4EBP1: mammalian 4E-binding protein 1 
AcCoA: Leu metabolite acetyl-coenzyme A 
AIM/ LIR: ATG8-interacting motif/ LC3-interacting 
region 
AMBRA1: mammalian VPS34 activator autophagy 
and beclin 1 regulator 1 
AMPK: mammalian AMP-activated protein kinase 
AP1: mammalian Adaptor protein 1, tetrameric 
clathrin-associated complex 
APT1: aberrant pollen transmission 1 
ARFIP: mammalian ADP-Ribosylation Factor 
Interacting Protein 1  
ATE1: Arginyltransferase 1 
BafA1: bafilomycin A1, specifically targets the 
vacuolar-type H+ -ATPase (V-ATPase) enzyme  
BAG3: BCL2 associated athanogene 3 
BAR: Bin/Amphiphysin/Rvs 
BCL2: mammalian BCL2 Apoptosis Regulator  
BECN1: ULK1 complex then phosphorylates 
beclin1 
BPAN: beta-propeller protein-associated 
neurodegeneration 
CAG: cytosine-adenine-guanine 
CathD: Cathepsin D 
CHMP: mammalian charged multivesicular body 
protein  
CMA: chaperone-mediated autophagy 
COPII: mammalian coat protein complex that 
initiates the budding process 
ER: Endoplasmic Reticulum 
ESCRT: endosomal sorting complexes required for 
transport 
Fab1: yeast homolog of PIKfyve 
(Phosphatidylinositol-3-
Phosphate/Phosphatidylinositol 5-Kinase, Type III) 
FAK: focal adhesion kinase 
FAME: familial adult myoclonic epilepsy 
Fig4: yeast homolog of FIG4 Phosphoinositide 5-
Phosphatase 
FIP200: mammalian 200 kDa FAK Family Kinase-
Interacting Protein 
FKBP12: the mammalian 12-kDa FK506-binding 
protein 
GABARAP: γ-aminobutyric acid receptor-
associated protein 
GABARAPL1: mammalian γ-aminobutyric acid 
receptor-associated protein-like 1 
GATE-16: mammalian Golgi-associated ATPase 
enhancer of 16 kDa 
GOLGA2: mammalian Golgin subfamily A member 
2 
GP: globus pallidus 




IGRM: mammalian immunity-related GTPase 
family M protein, also known as interferon-inducible 
protein 1 (IFI1) 
LDS: hydrophobic patch 
LGG-1, LGG-2: Caenorhabditis elegans ortholog of 
human GABARAP and LC3 respectively 
LKB1: mammalian liver kinase B1, also known as 
Serine/threonine kinase 11 (STK11). 
LTR: Lysotracker red 
LUV: large unilamellar vesicles 
MAP1LC3/ LC3: mammalian Microtubule-
associated protein 1A/1B-light chain 3 
MFN1/2: human mitofusin-1/2 
mLST8: mammalian lethal with Sec13 protein 8, 
also known as GβL 
mTOR: mechanistic target Of rapamycin 
MVB: multivesicular body 
NBIA: X-linked dominant subtype of 
neurodegeneration with iron accumulation 
NCOA4: nuclear receptor coactivator 4 
NRBF2: mammalian nuclear receptor binding factor 
2 
Nt: N-terminal 
p150: phosphoinositide‐3‐kinase regulatory subunit 
4 Vps15 
P62/SQSTM1, NDP52, NBR1, OPTN and TAXBP1 
PABC: Poly-Adenylation Binding Protein 
PE: phosphatidylethanolamine 
PI(3,5)P2: Phosphatidylinositol 3,5-bisphosphate 
(PtdIns(3,5)P2) 
PI3KC3: phosphatidylinositol 3-kinase class 3 
PI4K: mammalian phosphatidylinositol 4 kinase 
PI4P, PI5P:: phosphatidylinositol 4-phosphate and 
phosphatidylinositol 5-phosphate 
PLEKHM1: pleckstrin homology domain-
containing family M member 1 
PM: plasma membrane 
PMN: piecemeal of the nuclear 
polyQ: homomeric polyglutamine 
PROPPIN: mammalian β-propellers that bind 
phosphoinositide, also called WIPI  
RAB1A: mammalian Ras-related protein Rab-1A 
RAPTOR: mammalian regulatory-associated protein 
of mTOR 
RMC1: Regulator of MON1-CCZ1 complex, 
component of the CCZ1-MON1 RAB7 guanine 
exchange factor (GEF). 
S6K: mammalian ribosomal protein S6 kinase 
polypeptide 1 
SCA: spinocerebellar ataxias 
SENDA: static encephalopathy in childhood with 
neurodegeneration in adulthood 
SH3GLB1: mammalian Endophilin-B1, also BIF-1. 
SLC2A: mammalian SoLute Carrier Family 2 
Member 
SN: substantia nigra 
SNAP29: Synaptosomal-associated protein 29 
SNARE: Soluble NSF Attachment proteins (SNAP) 
Receptor 
STX17: mammalian Syntaxin 17. 
SUV: small unilamellar vesicles 
TfR: transferrin receptor 
TGN: Trans Golgi network, a part of the golgi 
apparatus in cells 
TGOLN2: Trans-Golgi network integral membrane 
protein 2 
TRAPIII: The transport protein particle, consists of 
trafficking protein particle complex (TRAPPC) 8,11 
and 12. 
TRAPPC5: mammalian trafficking protein particle 
complex 5 
UBA: ubiquitin associated 
UBR: ubiquitin recognin box 
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UDS: ubiquitin-docking site 
UIM: ubiquitin-interacting motif 
ULK: mammalian Unc-51 Like Autophagy 
Activating Kinase  
Vac7, Vac14: Vacuolar segregation protein 7 and 
Vacuolar segregation protein 14, both components 
of PIKfyve protein kinase complex. 
VAMP8: mammalian vesicle-associated membrane 
protein 8 
VPS34: mammalian Vacuolar protein sorting 34, the 
only known mammalian Class III 
phosphatidylinositol 3-kinase 
Vps4: vacuolar protein sorting-associated protein 4, 
yeast homolog of VPS4A,B. 
WD40 repeat: a short structural motif of 
approximately 40 amino acids, often terminating in 
a tryptophan-aspartic acid (W-D) dipeptide. 
WIPI: WD repeat domain phosphoinositide-
interacting 
YKT6: human Synaptobrevin homolog YKT6 
Ymr1: yeast homolog of phosphoinositide 3-
phosphatase 
Ypt1: yeast homolog of Ras-related protein Rab-1 
